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1 INTRODUCTION 
“Whereas most of us assess ourselves on the basis of our perceived 
performance in various domains – eg, relationships, work, parenting, sporting 
prowess – patients with anorexia nervosa (…) judge their self-worth largely or 
even exclusively, in terms of their shape and weight and their ability to control 
them.” (Fairburn & Harrison, 2003). 
 
There are two possibilities of losing weight: On the one hand the consumption 
of food can be decreased; on the other hand, the amount of activity can be 
increased. To be healthy, both features, eating and activity, have to be in 
balance. In anorexia nervosa (AN) this balance spirals out of control because of 
simultaneous strict food restriction and excessive exercise (Zipfel et al., 2013). 
Our task is to understand the complex interactions between eating behavior and 
activity behavior in AN. Therefore we have to apply our findings on treatment to 
help AN patients recover a healthy balance (Zunker, Mitchell, & Wonderlich, 
2011) (Gummer et al., 2015).  
 
1.1 Anorexia nervosa 
Anorexia nervosa (AN) is a mental disease affecting mainly young women 
(Zipfel, Giel, Bulik, Hay, & Schmidt, 2015). Severe underweight conditions, 
massive fear of weight gain, and body image disturbance are the primary 
characteristics of AN. An additional variety of psychiatric and somatic 
complications make it a very dangerous disease (Lowe et al., 2001). 
1.1.1 Epidemiology  
The lifetime prevalence of AN is about 1% in women and less than 0.3% in men 
(Treasure, Claudino, & Zucker, 2010) (Smink, van Hoeken, & Hoek, 2012) 
(Herpertz-Dahlmann, 2009). The point prevalence is assumed to be about 0.3% 
to 0.5%. AN can occur at any age, but it most often begins during puberty at the 
age of 13 to 19 years (Favaro, Caregaro, Tenconi, Bosello, & Santonastaso, 
2009). At this age the incidence is about 50 cases per 100,000 person-years 
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(Teufel et al., 2009). AN patients have little insight into the illness and reject 
seeing a doctor, which makes it difficult to register the AN population. Stability 
of AN incidence rates over the last decades can be assumed (Currin, Schmidt, 
Treasure, & Jick, 2005). The discussed increase of incidences in the last two to 
three decades (Smink et al., 2012) is probably due to a more careful process of 
making diagnoses in AN (Teufel et al., 2009). Due to significant changes in 
eating disorder diagnosis in the Diagnostic and Statistical Manual of Mental 
disorders, fifth edition (DSM-5) in comparison to the former DSM-IV criteria, an 
increase in AN diagnoses has been determined (Mustelin et al., 2016) 
(Mancuso et al., 2015).  
1.1.2 Diagnosis and classification of anorexia nervosa 
According to the DSM-5, three criteria must be recognized for the diagnosis of 
AN:  
 
1.)  Restriction of energy intake, leading to significantly low bodyweight 
(significantly low weight is defined as a weight that is less than minimally 
normal)  
2.)  Intense fear of gaining weight or becoming fat  
3.)  Disturbance in the way one’s body weight or shape is experienced 
(American Psychiatric Association’s Diagnostic and Statistical Manual of Mental 
Disorders, 2013). 
 
In the DSM-IV a fourth criterion was indicated in the diagnosis of AN: 
amenorrhea. This criterion was dropped in the DSM-5 (Roehr, 2013). The 
actual ICD-10 criteria are similar to the DSM-IV, and it has also been proposed 
that the ICD-11 drop amenorrhea as a criterion (Zipfel et al., 2015).  
Additionally, AN can be divided into two subtypes. The restrictive subtype is 
limited to restrictive eating without any other methods used to lose weight and 
without binge eating. The purging subtype describes a form of AN with 
symptoms of binge eating and purging behaviors such as self-induced vomiting, 
excessive exercise, or misuse of laxatives (Teufel et al., 2009).  
  3 
1.1.3 Etiology 
The etiology of AN is multifactorial. It includes heritable genetic factors, 
neurocognitive modifications like problems with the processing of emotions, 
structural changes in the brain, dysfunction in subcortical regions, 
malfunctioning of serotonergic and dopaminergic systems, stress and anxiety. It 
is also rooted in personality traits such as perfectionism or obsession as well as 
hormonal changes during puberty and environmental factors like “the 
sociocultural pressure to be thin” (Schmidt, 2003). All of these characteristics 
play a role in the development of AN (Zipfel et al., 2015). 
1.1.4 Complications and comorbidities 
AN can cause severe somatic and psychiatric complications. Every organ 
system can be involved (Teufel et al., 2009). The musculoskeletal system 
(osteoporosis and stress fractures), the cardiovascular system (bradycardia, 
hypovolemia, long QT time and arrhythmias), the gastrointestinal system 
(gastric acid irritations after periodical vomiting) and the electrolyte household 
(hypokalemia and hyponatremia) are often affected. Endocrinological 
disturbances can include, for example, amenorrhea, hypercortisolism with 
elevated stress levels or low-T3-syndrome (Casper, 2006). AN is also strongly 
associated with major depressive disorder, anxiety disorder (Holtkamp, Muller, 
Heussen, Remschmidt, & Herpertz-Dahlmann, 2005), obsessive-compulsive 
disorder (Davis, Kaptein, Kaplan, Olmsted, & Woodside, 1998) and alcohol 
dependency (Root et al., 2010). These psychiatric comorbidities lead to risk 
factors resulting in worse treatment outcomes and higher relapse rates 
(Steinhausen, 2002).  
1.1.5 Treatment of anorexia nervosa  
An important step in the process of treatment is the identification of patients with 
AN at all levels of care. AN patients tend to be ambivalent about treatment. 
Some are afraid of treatment (Mander, Teufel, Keifenheim, Zipfel, & Giel, 2013), 
and, therefore, a substantial number of AN patients do not access treatment 
voluntarily (Keski-Rahkonen et al., 2007). However, early identification of AN 
patients is specifically important in adolescents (Herpertz-Dahlmann, 2015) and 
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at early stages of the illness because then full recovery is likely possible (P. J. 
Hay, Touyz, & Sud, 2012). Family-based treatment is primarily evident among 
adolescents, while for adult patients there is a variety of different psychological 
treatment options including, for example, enhanced cognitive behavioral 
therapy, interpersonal psychotherapy, psychodynamic therapy, or focal 
psychodynamic therapy without any clear superiority of one method over 
another (Zipfel et al., 2015). Inpatient treatment is an option for severe disease 
episodes. During inpatient therapy the weight gain should range from 500 g to 
1400 g per week (P. Hay et al., 2014). Not only psychotherapy but also group 
therapy or physiotherapy can be part of a multidisciplinary inpatient therapy. 
Moreover, electrolytes, electrocardiogram (ECG) and fluids can be properly 
monitored (Herpertz et al., 2011).  
In the last decade new treatments, such as cognitive remediation therapy 
(Lindvall Dahlgren & Ro, 2014) and neurobiological methods, such as deep 
brain stimulation or transcranial direct current stimulation have been shown to 
be effective in severe AN (Lindvall Dahlgren & Ro, 2014) (Zipfel et al., 2015). 
Additionally, relapse prevention has started to play a larger role in AN treatment 
(Giel et al., 2015) as well as several different types of prevention programs 
(Bailey et al., 2014). Pharmacotherapy is still not a treatment option for AN 
(Fairburn & Harrison, 2003).  
1.1.6 Prognosis 
AN is known as a mental disease with high mortality rates (Sullivan, 1995) and 
a poor long-term prognosis. The standardized mortality rate has been stated to 
be 5.86 (Arcelus, Mitchell, Wales, & Nielsen, 2011). Death in AN is a result of 
the various complications of malnutrition; however cardiovascular complications 
seem to be most dangerous (Sachs, Harnke, Mehler, & Krantz, 2016). 
Moreover, there is a high risk of suicide in AN. Up to 20% of patients with AN 
attempt suicide (Franko & Keel, 2006). Only around half of the AN patients 
reach full recovery (Steinhausen, 2002) (Papadopoulos, Ekbom, Brandt, & 
Ekselius, 2009) even after treatment durations of more than five years (Zipfel et 
al., 2015). High levels of chronification have been observed, especially in 
adults. In addition, up to 30% of AN patients have a relapse after inpatient 
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treatment; others develop bulimia nervosa or atypical eating disorders (Teufel et 
al., 2009). However, the understanding of AN has improved in recent years, 
leading to more appropriate treatment. As a result, recovery rates have started 
to decline (Zipfel et al., 2015).  
A high age of onset, psychiatric comorbidities, a low body mass index (BMI) 
after first inpatient treatment, and high levels of physical activity (PA) elevate 
the risk of a poor treatment outcome in AN (Rigaud, Pennacchio, Bizeul, 
Reveillard, & Verges, 2011) (Strober, Freeman, & Morrell, 1997).  
1.2 Physical activity in Anorexia nervosa 
“…high levels of physical activity (PA) occur in 31 – 80% of patients with AN 
(Hebebrand et al., 2003) and lead to severe complications. Despite this fact, an 
elevated PA level is only a second order symptom for AN according to 
diagnostic and statistical manual 5. Increased PA in AN has been described 
since 1868 (Gull, 1997), but until today there is a lack of common definition for 
elevated PA in AN (Bratland-Sanda, Sundgot-Borgen, et al., 2010b). A great 
variety of descriptions can be found in the literature addressing the same 
phenomenon. Besides the various descriptions of manifestations, contradictory 
explanations of the causes and consequences of PA in AN can be found. The 
heterogeneity of hypotheses and evidence makes it difficult to measure and 
interpret PA in AN and difficult to compare the results.” (Gummer et al., 2015). 
1.2.1 Definitions and manifestations of physical activity in Anorexia 
nervosa 
“Physical activity in AN has been described as hyperactivity, overactivity, 
paradoxical overactivity, motor restlessness, diffuse restlessness, compulsive 
exercise or excessive exercise.” (Gummer et al., 2015) Rizk et al (2015) found 
seven different definitions for problematic exercise in AN. “This might be partly 
due to the various manifestations of PA in AN (Hebebrand et al., 2003): long-
distance running or cycling, excessive participation in fitness programs at the 
gym and any other type of high intensity PA or long-lasting sport are often 
practiced by affected patients. Besides sports, PA can be easily integrated into 
everyday activities such as uninterrupted fidgeting, standing instead of sitting 
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while studying or watching television, carrying heavy bags, taking the stairs 
instead of the elevator, walking instead of taking the bus or doing sit-ups in 
public restrooms. Whether the different terms describe the same phenomenon 
and whether psychological components such as inner restlessness are included 
remain unclear. We will use the term high level physical activity (HLPA) for all 
kinds of elevated PA (…) as it can be utilized for all forms of PA including sports 
and everyday activities, as an understandable topic term. This term has been 
used similarly before (Kostrzewa et al., 2013). HLPA includes PA but no 
psychological aspects such as inner restlessness.” (Gummer et al., 2015).  
1.2.2 Etiology of high level physical activity in Anorexia nervosa 
“The origin of HLPA in AN has been controversially discussed. HLPA can be 
seen as a conscious action with the aim to burn calories and control shape or 
weight, meaning the ‘relentless pursuit of thinness’ (Dalle Grave, Calugi, & 
Marchesini, 2008). But there is also evidence that HLPA can be an 
unconscious, uncontrolled symptom: neurobiological explanations for HLPA in 
AN have been reviewed by Matta Mello Portugal et al. (Matta Mello Portugal et 
al., 2013). This regulation by hormones would support the hypothesis that 
HLPA is a phylogenetically old mechanism for survival in a famine state 
(Scheurink, Boersma, Nergardh, & Sodersten, 2010). Leptin, for example, is a 
frequently discussed hormone that triggers the adaption of an organism to food 
restriction. Changes of body fat are reflected by plasma levels of leptin. Exner et 
al. (Exner et al., 2000) showed that administration of leptin reduced starvation-
induced hyperactivity in rats. Starvation-induced hyperactivity can be seen as a 
model for AN: semi-starved rodents reduce food intake when given access to a 
running wheel (Pierce, Epling, & Boer, 1986). However, whether or not, 
hyperactivity through hypoleptinemia is specific to AN could not be determined. 
Bouten, van Marken Lichtenbelt and Westerterp (Bouten, van Marken 
Lichtenbelt, & Westerterp, 1996) simply state that HLPA reduces the value of 
food reinforcement, which simplifies to an avoidance of food (Davis et al., 
1997). Excessive exercising is supposed to reduce rumination and the amount 
of time spent thinking about food or eating. Furthermore, excessive PA can 
reduce appetite. Cognitive behavioural components that influence HLPA have 
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to be addressed. According to Meyer, Taranis, Goodwin and Haycraft (Meyer, 
Taranis, Goodwin, & Haycraft, 2011), there are four main correlates of HLPA in 
eating disorder (ED): ED psychopathology, affect regulation, perfectionism and 
obsessive-compulsiveness. HLPA seems to serve as a similar function in the 
ED as purging or bulimia. The inability to cope with adverse mood states, 
anxiety or depression can be seen as explanation of the maintenance of HLPA 
in AN (Holtkamp, Hebebrand, & Herpertz-Dahlmann, 2004). In patients with 
high levels of ED psychopathology, exercise is associated with negative effects 
and elevated ratings of anxiety. Exercise has also been shown to decrease 
depressive symptoms (Bratland-Sanda, Sundgot-Borgen, et al., 2010a). HLPA 
might be similar to addictive behaviour (Scheurink et al., 2010). Positive 
reinforcement is reflected by an enjoyable state experienced during exercise. 
Our group showed that PA stimuli activate the reward system in patients with 
AN (K. E. Giel et al., 2013). Negative reinforcement is reflected by the 
avoidance of withdrawal symptoms such as guilt, anxiety or depression. The 
fear of negative consequences again results in compulsive operations such as 
HLPA. Compulsivity in general is linked with both HLPA and ED. Literature 
shows significant relationships between AN and obsessive-compulsive 
personality traits. Davis, Kaptein, Kaplan, Olmstedt and Woodside (Davis et al., 
1998) described the three aspects of obsessive-compulsive disorder, starvation 
and HLPA as a ‘self-perpetuation loop’. Another explanation by Carrera et al. 
(Carrera et al., 2012) presents HLPA as a strategy of thermoregulation. Patients 
with AN tend to often feel cold even while wearing warm clothes indoors 
(Hillebrand, de Rijke, Brakkee, Kas, & Adan, 2005).” (Gummer et al., 2015) 
1.2.3 Consequences of high level physical activity in Anorexia nervosa 
“Consequences of HLPA in AN patients include not only increased weight loss 
and a more severe ED psychopathology (Cook & Hausenblas, 2008), but also 
lethal cardiovascular and endocrinologic symptoms and problems of the 
muscular system (Bratland-Sanda, Sundgot-Borgen, Rosenvinge, et al., 2010) 
like overuse injuries, fatigue fractures and osteoporosis (Haddad, Bann, Hill, & 
Jones, 1997). HLPA is also associated with a higher rate of treatment dropouts, 
longer duration of illness (Kostrzewa et al., 2013) or treatment (Solenberger, 
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2001), a higher risk of relapse (Strober et al., 1997) and a poorer treatment 
outcome (Dalle Grave et al., 2008).” (Gummer et al., 2015)  
1.3 Measurement of physical activity in anorexia nervosa 
As the understanding of the relevance of HLPA in AN has become clearer in the 
past years the quantification of PA in AN has become a new challenge, not only 
in research but also in clinical context. 
1.3.1 Subjective measurement of physical activity in Anorexia nervosa 
“In the clinical context , HLPA has been assessed by various subjective 
methods like questionnaires (Higgins, Hagman, Pan, & MacLean, 2013), self-
ratings (Mond & Calogero, 2009) e.g. using visual analogue scales (Holtkamp et 
al., 2006) or activity diaries (Pirke, Trimborn, Platte, & Fichter, 1991), semi-
structured interviews (Davies, Parekh, Etelapaa, Wood, & Jaffa, 2008), 
observations by experts (Halmi, Goldberg, Casper, Eckert, & Davis, 1979) and 
analyses of medical records (Crisp, Hsu, Harding, & Hartshorn, 1980). Van 
Elburg et al. asked nurses to rate the levels of PA of their patients (van Elburg, 
Hoek, Kas, & van Engeland, 2007). These methods are prone to error and bias 
due to missing recall ability or compliance. Additionally, patients with AN seem 
to underreport PA because of their perception of what can be considered PA 
(Bratland-Sanda, Sundgot-Borgen, et al., 2010a).” (Gummer et al., 2015). 
1.3.2 Objective measurement of physical activity in Anorexia nervosa 
“Daily PA assessment requires an objective method that can be used under 
normal living conditions. In 1970, Blinder, Freeman and Stunkard (Blinder, 
Freeman, & Stunkard, 1970) first utilized objective experimental methods using 
a pedometer (a device that counts steps). Bouten, van Marken Lichtenbelt and 
Westerterp (Bouten et al., 1996) first used the doubly labelled water (DLW) 
method to assess PA in AN. This method is still used today (Zipfel et al., 2013). 
DLW measures the total daily energy expenditure over a period of up to 3 
weeks. It determines the average daily metabolic rate with the help of stable 
isotopes and combines it with the resting metabolic rate (Coward, 1988). The 
advantage of this method is accuracy concerning measurements and the 
experimenter is not dependent on the compliance of the participant. However, 
  9 
DLW is a complex, expensive technique, and the outcome does not provide 
activity patterns in time. This is why the current use of accelerometry seems to 
be the standard objective activity measurement method in AN.” (Gummer et al., 
2015).  
1.3.2.1 Technology of accelerometry 
“An accelerometer processes acceleration signals of the person wearing the 
accelerometer device and calculates the sum of the rectified and integrated 
acceleration curves from all three directions measured (longitudinal, transversal, 
sagittal). The final output is counts per minute.” (Gummer et al., 2015) The 
value of counts depends on the frequency and the intensity of the acceleration. 
The transformation of the raw acceleration into counts can be explained by a 
band-pass filter that exhibits low gain at very low frequency and at very high 
(un-human) frequency (Cain, Conway, Adams, Husak, & Sallis, 2013) “The 
result can be transformed into other units such as steps per hour, kilocalories 
per hour or metabolic equivalents. Besides energy expenditure, it also 
measures duration and intensity of PA and provides activity patterns through 
time. Plasqui, Bonomi and Westerterp (Plasqui, Bonomi, & Westerterp, 2013) 
reviewed the usage of accelerometry and drew the conclusion that 
accelerometers are best placed on the hip or lower back, although they can 
also be worn on the wrist, ankle or upper arm. Moreover, 3-5 consecutive days 
of monitoring seem to reliably estimate habitual PA. Trost, McIver, & Pate 
(Trost, McIver, & Pate, 2005) also found that one device per person is 
enough…” (Gummer et al., 2015) However, using more than one device in one 
person, the differentiation between for example sitting and standing improves, 
but simultaneously the wearing comfort and the practicability decreases 
(Plasqui et al., 2013). The epoch length should be one minute. “The epoch 
length is defined as the sampling interval. Some accelerometers have additional 
applications such as assessment of heart frequency, light intensity or skin 
temperature.” (Gummer et al., 2015) It could not be shown that those 
applications significantly improve the PA assessment (Plasqui et al., 2013).  
 
  10 
1.3.2.2 Development of accelerometry assessment in Anorexia nervosa 
“Comparison between the oldest and the newest device technology shows 
great developments in accelerometers, particularly in memory capacity, data 
storage, data evaluating software and wearing comfort. The oldest devices 
have incomparable technology: Falk, Halmi and Tryon (Falk, Halmi, & Tryon, 
1985) describe the actometer (Timex 108 motion recorder, Timex Group USA 
Inc., Middlebury, CT, USA) used in their study as a ‘man’s mechanical self-
winding wristwatch that has been modified such that the self-winding rotor 
directly drives the minute hand, which drives the hour hand and the calendar 
date in a normal fashion rather than winding the mainspring, which has been 
removed’. This procedure could only be utilized for four measurement periods 
spread throughout the day (waking up, lunch time, 6pm and bedtime). Thus, 
this accelerometer (…) does not assess activity continuously.  
Kaye et al. (Kaye et al., 1986) used a so-called acceleration-sensitive device 
that measures continuously. However, movement has to be cumulated because 
of the small memory storage; thus, one count always represents 16 
movements. The advanced for its time Tracmor device used by Bouten, van 
Marken Lichtenbelt and Westerterp (Bouten et al., 1996) still weighs 250g, while 
the newest devices like Actiwatch weigh only 18g. The newer Tracmor device 
used by Hechler et al. (Hechler et al., 2008) weighs 22g. Tracmor has to me 
attached to the lower back and is composed of an accelerometer unit and a 
portable data unit, which are connected by a flexible cable. More recent devices 
are always composed of only one unit. The device used most frequently in trials 
that have the aim to assess PA in AN is called ‘Actiwatch’ (Cambridge 
Neurotechnology, UK, 18g), validated by Puyau, Adolph, Vohra and Butte 
(Puyau, Adolph, Vohra, & Butte, 2002). An Actiwatch has to be placed at the 
right ankle and cannot be worn while swimming or showering. ‘ActiGraph’ (MTI 
model, USA, 19 g), validated by Freedson, Melanson and Sirard (P. S. 
Freedson, Melanson, & Sirard, 1998), has also been utilized in several studies. 
It works similar to ‘Actiwatch’ but is worn on the hip. Another device often used 
is the ‘SenseWear armband’ (Pro 3 armband, Pittsburg, USA, 45 g), which 
additionally measures heat flux, galvanic skin response and skin temperature so 
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that the wear-time can be validated. This is also possible with ‘Actiheart’, which 
combines a heart rate monitor with triaxial accelerometry. Actiheart has to be 
placed on the left side of the chest with two electrocardiogram electrodes and 
only weighs 8 g.” (Gummer et al., 2015) 
1.4 Research questions 
1.4.1 Methods establishment 
What is already known about accelerometry assessment in AN? 
In order to establish accelerometry as a method to assess PA in AN, we 
reviewed previous, objectively measured results. This provides an overview of 
different devices, utilization, combination of methods, validation, and limitations.  
1.4.2 Anorexia nervosa and exercise (ANEX) pilot study 
With the knowledge of the reviewed studies we construed the ANEX pilot study. 
The following questions defined this study:  
1.4.2.1 Comparison of inpatients and outpatients 
What are the differences concerning physical activity, eating disorder pathology, 
and psychopathology?  
In the ANEX pilot study we measured PA with accelerometry, both in inpatients 
and in outpatients with AN. Self-perceived PA was measured with 
questionnaires to compare the results of subjective and objective PA 
assessment in the groups. Additionally, we analyzed the attitudes toward 
activity through eating disorder questionnaires and psychometric 
questionnaires. We tried to determine the effect of inpatient treatment on PA 
behavior and how PA behavior is interrelated with eating disorder pathology 
and psychopathology.  
1.4.2.2 Comparison of inpatients and inpatients at follow-up 
How does physical activity behavior change after treatment?  
We performed an accelerometry assessment one month after treatment to 
compare the objectively-measured levels of activity during inpatient treatment 
and at follow-up. Thus, we tried to determine how PA developed after 
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hospitalization. This was another method used to identify if inpatient treatment 
had an effect on PA behavior.  
1.4.3 Feasibility 
Is accelerometry an appropriate method to assess physical activity in AN? 
The usage of accelerometry was discussed critically as well as an overview of 
what should be considered and what can be improved in accelerometry as a 
method of PA assessment in AN. Additionally, the differences between study 
refusals and the participants of the ANEX pilot study, which were based on 
clinical characteristics, psychometric questionnaires, and qualitative analysis 
were shown. Thereby we tried to obtain an understanding of why study refusals 
occur so frequently and determine why accelerometry assessment or PA 
assessment, in general, is a problem for patients with AN.  
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2 METHODS 
2.1 Study design 
In the ANEX (anorexia nervosa and exercise) pilot study the levels of PA of 
patients with AN relating to inpatient treatment and psychopathology were 
assessed. The measurement of PA was performed objectively with 
accelerometry and subjectively with questionnaires. Also the psychopathology 
was assessed with questionnaires. Additionally, we evaluated analyses of 
electrocardiogram (ECG) and physiologic parameters. The ANEX pilot study 
was construed to evaluate the feasibility of a larger ANEX study. 
2.2 Ethical approval 
The ANEX study was submitted by the ethical review committee of the Faculty 
of Medicine of the Eberhard – Karls – University Tuebingen in August 2013. 
2.3 Inclusion and exclusion criteria 
2.3.1 Inclusion criteria 
- female gender 
- inpatients or outpatients at University Hospital Tuebingen, Department 
for Psychosomatic Medicine and Psychotherapy 
- age > 18 years 
- diagnosis of Anorexia nervosa (ICD F50.0) or subsyndromal AN with BMI 
<18.5 kg/m² 
- informed written consent 
2.3.2 Exclusion criteria 
- significant substance abuse 
- acute psychotic disorder 
- bipolar disorders 
- acute suicidal tendency 
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2.4 Study procedure 
Patients were recruited from the Department of Psychosomatic Medicine and 
Psychotherapy at the University of Tuebingen. They were introduced to the 
ANEX study during the first appointment with the study staff. The meeting also 
aimed to answer questions and to discuss possible fears concerning the study. 
After this first appointment, AN patients were given the option of directly starting 
the first measurement or taking some time to think about their participation 
based on the written information that they received. All patients who finally 
decided to participate had to first complete a written consent form. Next they 
had to fill out the questionnaires, which included basis documentation and 
information regarding their PA, psychometric data, and eating disorders. 
Afterward they began the accelerometry measurement. The patients were 
instructed to wear the ActiGraph throughout four whole days except for when 
showering, swimming and sleeping. The outpatient group fulfilled one period of 
measurement, while the inpatient group had to fulfill two periods of 
measurement. This included four days of measurement during inpatient 
treatment about one month after admission and one follow-up measurement 
approximately one month after discharge (Figure 1).  
 
Figure 1: Study procedure  
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2.5 Physical activity assessment  
PA was measured objectively with accelerometry and subjectively with 
questionnaires.  
2.5.1 Objective PA assessment 
2.5.1.1 Physical activity assessment with the GT3X+ ActiGraph 
In the ANEX study we utilized ActiGraph devices (ActiGraph model GT3X+, 
Pensacola, USA) (Aadland & Ylvisaker, 2015). The device is attached to a belt 
and had to be worn around the waist for four consecutive days per 
measurement, except for when showering and during the night while sleeping. 
The ActiGraph is not only able to indicate whether a subject is standing, sitting 
or lying, but it also indicates when a device is not worn at all so that for example 
sedentary behavior and non-wear time can be distinguished. This is possible 
because in the absence of activity, when no counts are assessed, the total 
acceleration is measured in the down vector: When the device is worn around 
the waist and the subject is lying for example, the y–axis of the device reflects 
the down vector. If the ActiGraph is lying on a table, for example, the z-axis 
reflects the down vector (P.S. Freedson et al., 1998).  
The ActiGraph accelerometer does not have any additional applications, such 
as heart rate or temperature sensors. To improve the compliance and the wear-
time during the measurement periods, every participant had to make an activity 
diary with a focus on non-wear periods, meaning that the patient had to note 
when she showered, for example. Every participant received an information 
sheet with an explanation of how accelerometry works. Moreover, the study 
instructor always introduced the study to the patient and handed the device 
over personally. The patient could ask questions during this meeting and could 
contact the instructor whenever a problem arose during the measurement 
period. Additionally, the instructor contacted every patient during a 
measurement period on the second day via text message or email to ask if 
everything was going well with the ActiGraph. After the measurement the 
patient could get the results of the measurement for her own information.  
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2.5.1.2 Data analysis of the ActiGraph GTX3+ 
The analysis of the data of the ActiGraph devices was performed with the 
ActiLife software, which was provided by the ActiGraph company. After a 
measurement period the data had to be downloaded on a computer with 
ActiLife software. Activity data from day one to four was averaged to determine 
the mean daily physical activity for each patient. 
Before data could be analyzed and compared, it was important to flag the 
information that was collected when the device was not worn. The wear time 
validation (WTV) function of ActiLife provided a summary of non-wear and wear 
times. Non-wear times were excluded from further analysis. For our WTV we 
used defaults developed by Troiano (2007). Troiano (2007) defined that a non-
wear period has a minimum length of consecutive zeros of 60 minutes with a 
spike tolerance of 2 minutes, meaning that a detection of more than zero counts 
over a period of more than two minutes would end a non-wear-time period. The 
spike level to stop was defined as 100 counts per minute, meaning that a non-
wear period would end if a count level exceeding this value was encountered. 
Additionally, wear-time periods shorter than six minutes were ignored, so that 
the minimum length of an acceptable wear period had to be greater than six 
minutes. After WTV all data was calculated relating to the total wear time during 
the four measurement days of each participant so results could be more easily 
compared.  
Thereafter the data was summarized and could be transformed from counts per 
minute (CPM) into the following outcomes: percentage in light activity, 
percentage in moderate activity, percentage in vigorous activity and percentage 
in moderate to vigorous physical activity (MVPA), kcal/day, metabolic 
equivalents (METs) and steps/day. The cut point values (in counts per minute) 
for the activity intensities were 0 to 2689 for light, 2690 to 6166 for moderate, 
6167 to 9642 for vigorous and >9643 for very vigorous activity. This means that 
the MVPA minimum count was 2690. These values have been validated by 
Freedson et al. (1998). It was possible to calculate the energy expenditure 
(kcal/min) value of above 1951 counts using the following formula (P. S. 
Freedson et al., 1998):  
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If CPM > 1951 then 
kcals/min=(0.00094×CPM+(0.1346×BM-7.37418)) 
CPM = Counts per Minute 
BM = Body Mass in kg 
 
METs (metabolic equivalent of task) are multiples of the resting metabolic rate. 
One MET represents the amount of energy a person spends at rest, meaning 
also the amount of oxygen needed at rest or the power: 
 
1𝑀𝐸𝑇 =  
1 𝑘𝑐𝑎𝑙 
𝑘𝑔∗ℎ 
  =  
3,5 𝑚𝑙 𝑂2
𝑘𝑔∗𝑚𝑖𝑛
  =   58,2 
𝑊
𝑚2
 
 
The MET rate gives us multiples of the basal metabolic rate. 1.5 to 3 METs are 
defined as low PA; 3 to 6 METs are defined as moderate PA; and more than 6 
METs are defined as exhausting PA (Ainsworth et al., 2011). A MET rate of 1.8 
METs over a whole day represents a hard-working person. With the following 
formula the MET rate can be calculated with the number of average counts per 
minute (P. S. Freedson et al., 1998): 
 
MET Rate = 1.439008 + (0.000795 * CPM) 
CPM = Counts per Minute 
 
2.5.2 Subjective PA assessment 
In the ANEX study four different questionnaires were used to assess PA. Each 
questionnaire addressed different aspects of PA in AN, which explains the 
usage of more than one questionnaire. 
2.5.2.1 IPAQ (International Physical Activity Questionnaire) 
We used the German short version of the IPAQ, which was validated by Craig 
et al. (2003). This questionnaire assesses the time spent in specific types of 
activity (sitting, walking, moderate, and vigorous activity) during the previous 
seven days. It is also possible to calculate a total score of physical activity 
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during one week and to define a category of the activity level into low, 
moderate, or high exercise. Additionally, it is possible to calculate kilocalories 
spent per week. The results of the continuous values are presented in MET-
minutes per week. One MET is the metabolic equivalent of task and is defined 
as resting metabolic rate (4,184 𝑘𝐽 ×  𝑘𝑔−1 ×  ℎ−1). The specific types of activity 
are represented by multiples of the resting metabolic rate (vigorous = 8 METs, 
moderate = 4 METs, walking = 3.3 METs). For the total score, the particular 
MET score has to be multiplied by the minutes performed in the certain type of 
activity and the number of days performed during the week. The results are 
standardized for a person who weighs 60 kg. For transformation of METs into 
kilocalories the weight of the test person has to be taken into account. 
2.5.2.2 CES (Commitment to Exercise Scale) 
The CES assesses the individual’s importance to exercising and the extent of 
exercising, reflecting both attitudinal and behavioral aspects. The German 
version of the test consists of eight items with continuous visual analogue 
scales (15.5cm) with bipolar adjectives at each end (for example: “never” and 
“always”). The score corresponds to the distance from the beginning of the 
scale to the cross of the test person on the scale. The total value is calculated 
by the mean of all eight items proportionally on a scale with ten points. The 
questions deal with the well-being influenced by exercising, the adherence to 
exercise despite adverse conditions, such as illness and the interfering of 
exercise with one’s social life. Item 7 has a special value especially for patients 
with AN and was interpreted as a single score in this study. (Do you feel “guilty” 
that you have somehow “let yourself down” when you miss your exercise 
session?) (Mond & Calogero, 2009). The original English version of the CES 
was validated by Davis and Fox (1993).  
2.5.2.3 REI (Reasons for Exercise Inventory) 
We used the German version of the REI which is similar to the English original 
version: a 24-item scale that measures the motivation for exercise on a 7-point 
scale (from “not at all important” to “extremely important”). The aim is to find the 
specific reasons that people actually have for exercising. Reasons for exercise, 
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such as “to lose weight” or “to improve my mood” can be found as items, for 
example. The REI subscales, which result from the single items are weight 
control, fitness, health, body tone, physical attractiveness, mood improvement, 
and enjoyment (Cash, Novy, & Grant, 1994).  
2.5.2.4 Questionnaire for registration of sports activities 
The questionnaire for registration of sports activities assesses the kind of sports 
that the participant is involved in and the intensity of this engagement. The first 
question is: “Do you presently participate in sports?” This can be answered by 
“yes” or “no”. When the answer is “yes” the sports activity must be defined. 
Then the number of units per month in this particular sports activity has to be 
given. Moreover, the duration of each unit has to be defined. Choices include 
“less than 15 minutes,” “15 – 30 minutes,” “30 – 45 minutes,” “45 – 60 minutes,” 
and “more than 60 minutes”. Up to six different sports activities can be named. 
The result of this questionnaire shows the type of sports that are important in 
the sample. The questionnaire was construed by the Psychosomatic 
Department of the University of Tuebingen.  
2.6 Psychometric instruments 
2.6.1 Clinical diagnostics  
2.6.1.1 BaDo (basis documentation) 
To assess general biopsychosocial stress, social data, and medical history we 
utilized the basis documentation of the Department of Psychosomatic Medicine 
and Psychotherapy at the University of Tuebingen, which was introduced to the 
psychosomatic care units by the German Ministry of Health in 1994 with the aim 
to improving quality control. Basis documentation is used for every patient in 
this department (Heuft, Senf, Wagener, Pintelon, & Lorenzen, 1996).  
2.6.1.2 PHQ (Patient Health Questionnaire) 
The PHQ assesses the most common mental disorders on the basis of the 
DSM-IV. It was developed by Spitzer, Kroenke and Williams (1999). It 
determines major depressive syndrome, panic syndrome, alcohol syndrome, 
and eating disorders (binge eating and bulimia nervosa). Additionally, scales for 
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the “intensity of depression” are calculated from 9 items as well as a scale for 
“somatic symptoms” using 15 items and a scale for “stress” containing 10 items. 
This reflects the severity of the mental disorder. The PHQ also assesses the 
GAD-7-scale (generalized anxiety disorder), which is calculated based on seven 
questions. The German version of the PHQ (Gesundheitsfragebogen für 
Patienten, PHQ-D) was utilized in the ANEX study and was validated by Löwe 
et al. (2010).  
2.6.1.3 PSQ (Perceived Stress Questionnaire) 
The PSQ is used to assess a person’s level of stress. It consists of four scales 
(worries, tension, joy, and demand) with five items each. For each item there 
are four possible answers: “almost never,” “sometimes,” “often,” and “usually”. 
The patient determines how often activities occurred during the previous four 
weeks. One item says, for example: “You have too many things to do”. The 
PSQ was developed by Levenstein et al. (1993). The shorter German version of 
the PSQ, which was utilized in the ANEX study, was validated by Fliege et al. 
(2005). The original questionnaire consists of 30 rather than 20 items. The first 
three scores (worries, tension and joy) represent internal stress reaction, 
whereas the fourth one (demand) stands for the perception of external 
stressors. The polarity of the joy score has to be reversed so that a high mean 
value of the PSQ scales stands for a high level of stress.  
2.6.2 Eating disorder diagnostic 
2.6.2.1 EDE (Eating Disorder Examination) questionnaire 
The EDE questionnaire is used to assess the specific pathology of eating 
disorders. The questionnaire consists of four subscales: restraint, eating 
concerns, shape concerns and weight concerns. Each scale has five to eight 
items, from which a mean value is calculated. The restraint scale and the eating 
scale show dysfunctions in eating behavior like feelings of guilt, while the shape 
scale and the weight scale indicate concerns about the body. Additionally, 
restrictive eating behaviors, such as “misuse of laxatives,” “misuse of diuretics,” 
“self-induced vomiting,” or “excessive exercising” can be identified by the EDE-
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Q. The German version of the EDE that was utilized in the ANEX study was 
validated by Hilbert, de Zwaan and Braehler (2012).  
2.6.2.2 EDI (Eating Disorder Inventory) 
The EDI allows identification of the presence of an eating disorder. It can be 
used to distinguish between anorexia nervosa, both restrictive and purging 
types, bulimia nervosa, eating disorders not otherwise specified, and binge 
eating disorder. The questionnaire consists of 91 items. Each item is a 
statement that can be answered by “always,” “usually,” “often,” “sometimes,” 
“rarely,” or “never”. The possible answers are valued from 1 to 6. Eleven 
subscales are included: drive for thinness, bulimia, body dissatisfaction, 
ineffectiveness, perfectionism, interpersonal distrust, interoceptive awareness, 
maturity fears, asceticism, impulse regulation, and social unsureness. For the 
ANEX study, we particularly focused on “drive for thinness,” “perfectionism,” 
and “body dissatisfaction” because these aspects are most common in AN. We 
used the German version of the EDI, which was validated by Thiel et al. (1997). 
Zipfel et al. proposed the EDI item “What percentage of your exercise is aimed 
at controlling your weight” as a simple tool to divide study participants with AN 
into high-level exercisers and low-level exercisers (Zipfel et al., 2013). The 
separation was made using a cut-offset at less than 50%.  
2.6.2.3 BIQ-20 (Body Image Questionnaire) 
The BIQ-20 questionnaire is a test that consists of 20 items that aim at 
measuring the subjective body image and quantifying a body image 
disturbance. For each item there are five possible answers: “does not apply,” 
“hardly applies,” “partly applies,” “largely applies” and, “absolutely applies”. The 
answers were rated numerically from one (“does not apply”) to five (“absolutely 
applies”). The questionnaire covers two dimensions, each with ten items: the 
“negative evaluation of the body” (NEB) and the “perception of body dynamics” 
(PBD). The “negative evaluation of the body” represents the appraisal of one’s 
own body, meaning, on the one hand, the appearance, and on the other hand, 
the feeling of well-being with one’s own body. In this rating patients with body 
image disturbances like patients suffering from AN or transsexualism attain high 
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counts. The value for the first dimension can be seen as pathological in patients 
with AN when it exceeds 37. The second dimension, “perception of body 
dynamics” describes how much power, fitness, or health are felt by the patient, 
representing the movement and energetic aspects of the body. Low counts in 
this dimension represent depressive aspects of the body and seem to be more 
unspecific. This second dimension can be seen as pathological when the score 
goes under 19. The BIQ-20 was validated by Clement and Lowe (1996).  
2.7 Physiologic parameters 
2.7.1 Body – Mass – Index (BMI) 
The BMI represents how height and weight of one person interact. The patients 
in the ANEX pilot study were weighed at the beginning of treatment. Inpatients 
with AN are weighed more often during the treatment, of course. The following 
formula represents the BMI: 
 
𝐵𝑀𝐼 =
𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑘𝑔)
𝑏𝑜𝑑𝑦 ℎ𝑒𝑖𝑔ℎ𝑡 (𝑚)2
 
2.7.2 Laboratory 
All inpatients at the Department of Psychosomatic Medicine and Psychotherapy 
at the University of Tuebingen had blood taken as a routine at the beginning of 
treatment and the results were indicated as part of this study. The TSH (thyroid 
stimulating hormone), the number of leukocytes, the red blood count, and the 
hemoglobin were especially considered in the ANEX study.  
2.7.3 ECG 
As cardiovascular complications seem to be common in AN, all inpatients were 
routinely given an ECG at the beginning of treatment. For the ANEX study we 
utilized the QT interval in percent and the heart rate.  
2.8 Statistics  
The software SPSS was used to analyze all data. A descriptive analysis of the 
samples was done, comparing the outpatient control group and inpatient group 
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and in the end the inpatient group with its follow-ups and the outpatient group 
with the inpatient group at follow-up (IG_FU) (Figure 2). 
 
 
Figure 2: Relations of the different samples as basis of statistical analysis 
 
Due to the explorative character of the ANEX study the level of significance was 
set at 0.05. Normal distribution of the study populations was assessed with the 
Kolmogorov-Smirnov test. Subsequently, we calculated with the help of the 
Wilcoxon and Mann-Whitney tests. We calculated effect sizes (Cohen’s d) to 
evaluate practical relevance with the following formula: 
 
𝑑 =  
(𝑋𝐸𝐺 − 𝑋𝐶𝐺)
𝑠
 
 
𝑠 =  
√𝑆𝐷𝐸𝐺
2 + 𝑆𝐷𝐶𝐺
2
2
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Cohen’s d > 0.8 is defined as a large effect. Cohen’s d between 0.5 and 0.8 is a 
medium effect, and a d between 0.2 and 0.5 is a small effect (Leonhart, 2004). 
We calculated correlations using the Spearman and Pearson correlation 
methods.  
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3 RESULTS 
3.1 Systematic review of the literature 
A systematic review of the literature, “High Levels of Physical Activity in 
Anorexia Nervosa: A Systematic Review” was published in the European Eating 
Disorder Review in 2015. Relevant results are given here. For further 
information, see Gummer et al. (2015). Twenty studies between 1985 and 2015 
were identified as shown in Table 1. Since then one more trial using 
accelerometry as PA assessment method in AN was published (Gianini et al., 
2016). A significant heterogeneity of study populations, measurements, device 
specifications, settings, and outcomes was found and resulted in a qualitative 
analysis.  
3.1.1 Sample characteristics in included studies 
“In the 20 reviewed trials, population size varied from 8 to 59 women (mean n = 
31,3). Eleven studies dealt with inpatients with AN, while six trials had 
outpatients with AN as participants. Three studies had both outpatients and 
inpatients in their study population (Kostrzewa et al., 2013) (Carrera et al., 
2012) (Keyes et al., 2015). Two of the trials explicitly focused on long-standing 
patients (Bratland-Sanda, Sundgot-Borgen, Rosenvinge, et al., 2010) (Bratland-
Sanda, Sundgot-Borgen, et al., 2010b) and one focused on acute AN patients 
(Holtkamp et al., 2006). In two studies patients with ED in general were 
assessed, comparing AN, bulimia nervosa (BN), and eating disorders not 
otherwise specified (EDNOS) (Bratland-Sanda, Sundgot-Borgen, Rosenvinge, 
et al., 2010) (Bratland-Sanda, Sundgot-Borgen, et al., 2010b).  Three studies 
included women recovered from AN (Dellava, Hamer, Kanodia, Reyes-
Rodriguez, & Bulik, 2011) (Harris, McAlpine, Shirbhate, Manohar, & Levine, 
2008) (Hechler et al., 2008). Eight of the 20 studies had a healthy normal 
weight control group; one compared AN patients with obese control patients 
(Westerterp & Bouten, 1997), while another compared AN inpatients and AN 
outpatients with either patients suffering moderate anxiety or healthy controls 
(Keyes et al., 2015). 
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In four studies, the study population was divided into a group of high 
exercisers/excessive exercisers(EE)/HLPA and low exercisers/non excessive 
exercisers(NEE)/LLPA. Two (Klein, Mayer, Schebendach, & Walsh, 2007) 
(Bratland-Sanda, Sundgot-Borgen, et al., 2010b) used the classification of 
EE/NEE suggested by Davis et al. (Davis et al., 1997) that defines patients as 
EE when they meet 3 criteria: (1) > 6h per week of accelerometry assessed 
MVPA (moderate to vigorous physical activity >1952 counts/min) upon 
admission; (2) reported persistence of this amount for > 1 month before 
admission; and (3) classification as exercise dependent symptomatic. Although 
Klein et al. (Klein et al., 2007) used the classification by Davis et al., they used 
the term ‘high exerciser’ instead of ‘excessive exerciser’. Kostrzewa (Kostrzewa 
et al., 2013) simply classified by the amount of time spent in MVPA measured 
by accelerometry. Hofman et al. (Hofmann et al., 2014) divided the groups by 
the median of steps in one day. Due to the different classifications, the 
percentage of participants belonging to the HLPA group varies in the different 
studies from 29% to 41.7%. The mean age varies from 12.8 to 33 years (mean 
= 24.4 years). Four studies included only adolescents, 6 studies included only 
adults (>17 years), and 10 studies included participants of every age.  
Mean BMI in the particular studies varied from 14.3 to 18.0 kg/m² (mean BMI = 
16.4 kg/m²) in the AN groups. Most studies had participants with a mean BMI of 
14 to 16 kg/m². Only one study did not fit in with a mean BMI of 18 in the study 
population, which was explained by the high muscle mass of two participants 
(Birmingham, Hlynsky, Whiteside, & Geller, 2005).” (Gummer et al., 2015) 
3.1.2 Problems with study dropouts 
“Dropouts were mentioned in 11 studies. In other studies, up to one third of the 
participants had to be excluded from analyses. This was mostly because of 
missing data from the accelerometer (Kostrzewa et al., 2013) (Dellava et al., 
2011) (Carrera et al., 2012) (Klein et al., 2007) (Birmingham et al., 2005) (Keyes 
et al., 2015) which was due to malfunctions, inactivity of the participant 
indicating misuse of the accelerometer, or when the accelerometer was not 
worn long enough per day. However, it is mostly impossible to discern whether 
data are incomplete due to technological limitations or non-compliance. In one 
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study (El Ghoch et al., 2013), ten patients dropped out of a 20-week treatment 
program, so the reason for dropping out was not associated with the 
accelerometer but probably with the long duration of the study. This was also 
the case for two studies where consecutive patients refused participation in the 
study (Bratland-Sanda, Sundgot-Borgen, Rosenvinge, et al., 2010) (Bratland-
Sanda, Sundgot-Borgen, et al., 2010b). Bouten et al. (Bouten et al., 1996) 
excluded one participant from the study because of excessive sport activity. 
Fernandez-del-Valle et al. (Fernandez-del-Valle et al., 2014) described the 
process of inclusion very precisely in a flow diagram showing that most drop-
outs quit the study not for intrinsic but external reasons such as concurrent 
hospitalization or care center relocation. None of the studies discussed 
problems and difficulties in recruitment and compliance of AN patients within the 
study context. Keyes et al. (Keyes et al., 2015) stated that the recruitment for a 
PA study might be biased since not all people with AN would participate.” 
(Gummer et al., 2015) 
3.1.3 Assessment of physical activity in Anorexia nervosa 
“In almost all trials one accelerometer per participant was used, but it was worn 
on different body positions. Only Falk et al. (Falk et al., 1985) utilized one 
device at the dominant wrist and another one on the ipsilateral ankle. In all 
studies the epoch length was set to 1 min, so that activity categories of 
counts/minute could be defined. The categorization was heterogeneous and 
only scarcely described. For example, Bouten et al. (Bouten et al., 1996) 
defined outputs of <1000 counts/minute as lying/standing/sitting activity, outputs 
of 1000 - 3000 as counts/minute as walking/cycling, and outputs of >3000 
counts/minute as household/sports/exercise. In contrast, the classification in the 
trial of Bratland-Sanda, Sundgot-Borgen et al. (Bratland-Sanda, Sundgot-
Borgen, et al., 2010b) defines activity with >1950 counts/minute as moderate to 
vigorous physical activity (Davis et al., 1997). Carrera et al. (Carrera et al., 
2012) and Kostrzewa et al. (Kostrzewa et al., 2013) used a classification by 
Puyau et al. (Puyau et al., 2002) that defines <200 counts/minute as sedentary 
activity, 200-1800 counts/minute as light activity, and >1800 counts/minute as 
moderate to vigorous activity for a device worn on the lower leg.  
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Comparison between the oldest and the newest device technology shows great 
developments in accelerometry, particularly in memory capacity, data storage, 
data evaluating software, and wearing comfort. The two oldest devices have 
incomparable technology: Falk et al. (Falk et al., 1985) describe the actometer 
(Timex 108 motion recorder) used in their study as a ‘man‘s mechanical self-
winding wristwatch that has been modified such that the self-winding rotor 
directly drives the minute hand, which drives the hour hand and the calendar 
date in a normal fashion rather than winding the mainspring, which has been 
removed’ (Falk et al., 1985). This procedure could only be utilized for four 
measurement periods spread throughout the day (waking up, lunch time, 6pm, 
and bedtime). Thus, this accelerometer is the only one of the review that does 
not assess activity continuously.  
Kaye et al. (Kaye et al., 1986) used a so-called acceleration-sensitive device 
that measures continuously. However, movement has to be cumulated because 
of the small memory storage; thus, one count always represents 16 
movements. The advanced for its time Tracmor device used by Bouten et al. 
(Bouten et al., 1996) still weighs 250g, while the newest devices like Actiwatch 
weigh only 18g. The newer Tracmor device used by Hechler et al. (2008) 
weighs 22g.  Tracmor has to be attached to the lower back and is composed of 
an accelerometer unit and a portable data unit, which are connected by a 
flexible cable. More recent devices are always composed of only one unit. The 
device used most frequently in the trials of this review is called ‘Actiwatch’ 
(Cambridge Neurotechnology, UK, 18g), validated by Puyau et al. (Puyau et al., 
2002). An Actiwatch has to be placed at the right ankle and cannot be worn 
while swimming or showering. ‘ActiGraph’ (MTI Model, USA, 19g), validated by 
Freedson et al. (P. S. Freedson et al., 1998), has also been utilized in several 
studies. It works similar to ‘Actiwatch’ but is worn on the hip. Another device 
often used is the „Sense Wear Armband“ (Pro 3 armband, Pittsurg USA, 45g), 
which additionally measures heat flux, galvanic skin response, and skin 
temperature so that the time it is worn can be validated. This is also possible 
with ‘Actiheart’, which combines a heart rate monitor with triaxial accelerometry. 
Actiheart has to be placed on the left side of the chest with two ECG electrodes 
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and only weighs 8g. One other device (RT3), utilized in the study of Birmingham 
et al. (Birmingham et al., 2005), has not been further described. 
Assessment in most trials of this review included not only PA measurement with 
accelerometry, but also different types of questionnaires or diaries, etc., with the 
purpose of assessing all types and manifestations of PA and sports behaviour 
in AN. These methods can be seen in table 1.” (Gummer et al., 2015) 
3.1.4 Time and duration of accelerometry assessment 
“The duration of the assessment varied from 2 days to 7 days (mean = 4.5 
days). Participants of all studies had to fulfil consecutive measurements.  
PA measurement took place in an inpatient setting in most cases. In most 
studies, only one PA assessment was performed, which again was most often 
in the first weeks of inpatient treatment. Four studies performed three PA 
assessments. In one of those, PA was assessed 3 times during inpatient 
treatment (Bratland-Sanda, Sundgot-Borgen, et al., 2010b), and in another trial 
it was assessed at the beginning and at the end of inpatient treatment, as well 
as at the one-year follow-up. Hechler et al. (Hechler et al., 2008) measured in 
three different seasons of the year (winter, autumn, and summer). Fernandez-
del-Valle et al. (Fernandez-del-Valle et al., 2014) measured PA before and after 
a high-intensity resistance training program and 4 weeks after detraining. 
Another trial included 2 measurements: at the beginning and at the end of 
treatment. Harris et al. (Harris et al., 2008) performed an experimental 
validation of PAMS. This study was excluded in the calculation of mean 
assessment duration.” (Gummer et al., 2015) 
3.1.5 Clustered outcome topics 
Clusters of studies with similar outcomes topics were made to get a better 
overview of the very different outcome parameters in the different studies.   
3.1.5.1 Validation of accelerometry 
“There are 5 studies that had the aim to validate a new method of PA 
assessment in AN. Westerterp & Bouten (Westerterp & Bouten, 1997) 
compared accelerometry with the DLW gold standard of PA assessment in 
1997, and showed that the new method of accelerometry is as valid as DLW in 
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measuring daily activity in AN. Birmingham et al. (Birmingham et al., 2005) tried 
to develop a new equation to calculate the calorie requirement for refeeding in 
AN. They assumed that smoking cigarettes, anxiety, and PA have an influence 
on weight gain, which could not be confirmed by the results. Harris et al. (Harris 
et al., 2008) aimed to validate PAMS (Physical Activity Monitoring System). 
They could show that accelerometry is sensible and specific in distinguishing 
between lying, sitting, standing, and walking with different velocities, meaning 
that the acceleration of the device correlates with the energy expenditure and 
the walking velocity. Another discovery was made by van Elburg et al. (van 
Elburg et al., 2007), who found that evaluation of PA by nursing staff during 
inpatient treatment correlates with accelerometry results. They also found that 
self-ratings of PA in AN underestimate the real amount of PA. This was also 
affirmed by Alberti et al. (Alberti et al., 2013), who compared objective and 
subjective measurement of PA in AN.” (Gummer et al., 2015) 
3.1.5.2 Controlled trials assessing physically active behaviour in anorexia 
nervosa 
“In five studies, PA in AN patients and normal weight controls were compared. 
El Ghoch et al. (El Ghoch et al., 2013) and Bratland-Sanda, Sundgot-Borgen et 
al. (Bratland-Sanda, Sundgot-Borgen, et al., 2010b) measured higher PA levels 
in AN than in the controls, while Bouten et al. (Bouten et al., 1996), Hechler et 
al. (Hechler et al., 2008), Keyes et al. (Keyes et al., 2015) measured similar 
levels of mean daily PA in AN. However, Bouten et al. (1996) showed that AN 
patients had either very high or very low activity levels, while controls had 
moderate activity levels. Keyes et al. (2015) found that self-reported activity was 
higher than objectively measured PA in AN, as well as that participants with AN 
had a higher „drive to exercise“. 
 Hechler et al. (2008) found that time spent in low-moderate intensity activity 
was higher during summer in both groups, AN patients and healthy controls.  
Some studies did not compare AN patients with healthy controls, but rather 
patients with high level physical activity (HLPA) and low level physical activity 
(LLPA). They found that AN patients with HLPA were affected earlier by AN, the 
illness duration was longer, and the patients showed more fat tissue and higher 
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leptin levels after recovering (Kostrzewa et al., 2014). Also, for patients with 
HLPA, PA was more important in regulating negative affects than for patients 
with LLPA (Bratland-Sanda, Sundgot-Borgen, et al., 2010b). In comparison with 
LLPA, HLPA patients also had higher scores in the Commitment to Exercise 
Scale, which shows an association between activity behaviour before inpatient 
treatment and during inpatient treatment.” (Gummer et al., 2015) 
3.1.5.3 Physical activity after recovery 
“Beside this, there are two studies dealing with recovered AN patients. Dellava 
et al. (2011) aimed to find why recovered AN patients have a longstanding 
lower BMI. For this purpose, they measured diet and PA, as well as reasons for 
diet and PA in AN and healthy controls. They could not show any differences 
between diet and PA in quantity, but recovered AN patients instead chose food 
for health reasons. Kaye et al. (1986) found that short term recovered AN 
patients had significantly higher calorie intake and PA levels than long-term 
recovered AN patients and controls. Thus, HLPA regressed after recovery. 
Hechler et al. (2008) included recovering AN patients in various stages of 
treatment. They found that the percentage of body fat was negatively correlated 
to PA, meaning that less PA could lead to a normalization of body fat.” 
(Gummer et al., 2015) 
3.1.5.4 Investigated interrelations of physical activity and biological 
factors  
“Six studies in this review had the purpose of finding a relation between PA 
level and certain factors. Falk et al. (1985) found that PA level in inpatients is 
suppressed by administration of cyproheptadine. Bouten et al. (1996) and 
Westerterp et al. (1997) found that high PA levels only occur in patients with a 
relatively high BMI (BMI of 17 kg·m-2 or more). Holtkamp et al. (2006) showed a 
U-formed relation between PA levels and serum levels of the hormone leptin, 
while Klein et al. showed a positive correlation between cortisol levels and PA 
levels (Klein et al., 2007). Carrera et al. (2012) found an association between 
activity levels and ambient temperature, which displays PA in AN as a strategy 
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for warming up, besides burning calories (Dellava et al., 2011).” (Gummer et al., 
2015) 
3.1.5.5 Correlations of physical activity behaviour and treatment 
“Four studies focus on the treatment of AN and how PA level and therapy 
interact. Kostrzewa et al. (2013) investigated how high activity levels are 
influenced by inpatient treatment and found that the PA level normalizes during 
treatment. They also found that AN patients who are classified as HLPA before 
inpatient treatment did not have higher recovery rates than patients with low 
level PA. Despite this, HLPA leads to longstanding consequences in recovery of 
leptin serum levels and body composition. In contrast, El Ghoch et al. (2013) 
found that treatment dropouts have almost twice as high PA levels than 
completers at the beginning of treatment. Falk et al. (1985) found that PA level 
increases in the first two weeks of inpatient treatment.  
Alberti et al. (2013), however, showed that the more time spent in light PA at the 
beginning of the treatment, the less improvement can be seen in ED 
psychopathology at the end of therapy. In this context Bratland-Sanda et al. 
(2010) found that a reduction of PA in general correlates positively with ED 
psychopathology. Especially in HLPA patients with ED, an improvement in ED 
psychopathology seems to result in a reduction in sport dependence and 
importance of PA to regulate negative effects. Additionally, Carrerra et al. 
(2012) showed that the more time spent in moderate to vigorous PA, the less 
anxiety occurs in AN. Holtkamp et al. (2006) showed that there is a relation 
between motor restlessness and inner restlessness. In contrast, El Ghoch et al. 
(2013) and Klein et al. (2007) could not find any significant association between 
ED psychopathology and PA. Falk et al. (1985) could not find a correlation 
between depression scales or personality measurements and PA. This shows 
that findings concerning psychopathology in general and other psychological 
measurements related to objectively measured PA in AN are highly 
contradictory.” (Gummer et al., 2015)  
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Table 1: Overview of literature about objectively measured physical activity in anorexia nervosa (Gummer et al., 2015) 
Study Sample 
Mean 
age 
Assessment Time of assessment 
Duration of 
assessmen
t 
Objective/ Purpose Results 
Keyes et al., 
2015 
 
Four groups: 
-18 AN inpatients 
-37 AN outpatients 
-34 anxiety patients 
-30 healthy controls  
 
28,3 -accelerometry (Actiwatch) 
-questionnaires for ED pathology 
and anxiety 
-questionnaires for PA, reasons 
for exercise and drive for 
exercise 
-body composition (Inbody 3.0 
Biospace machine) 
 
not further defined 1 week -find relationship between PA, drive for exercise, 
anxiety and ED pathology 
-no significant differences in objectively 
measured PA between groups 
-self-perceived PA higher than objectively 
measured PA in AN groups 
-type of exercise: AN outpatients reported more 
walking and moderate exercise, AN inpatients 
reported more walking and less moderate or 
vigorous PA than other groups 
-higher drive for exercise in AN groups 
-reasons for exercise vary between groups: 
“improving tone” most important for AN groups 
 
 
Fernandez-del-
Valle et al., 
2014 
36 AN (restricting type) 
divided into two groups: 
- intervention group 
(n=18) 
- control group 
(n=18) 
12,8 -accelerometry (ActiGraph) to 
ensure that patients were not 
excessive exercisers 
-muscular strength (weightlifting 
training machines) 
-BMI 
-agility (Timed Up and Go 
3m/10m) 
-before intervention 
-directly after 
intervention 
-4 weeks after 
intervention 
Not further 
defined 
-find out if 8 weeks of high-intensity resistance training 
(3 times a week) is able to rise muscle strength and 
agility without weight loss in AN restricting type 
-measure the persistence of the program 
-PA was no outcome criterion, and there are no 
results reported 
-in the intervention group strength increased 
significantly after 8 weeks training program 
-agility improved in the intervention group 
-effects persisted after end of therapy 
 
Kostrzewa et 
al., 2014 
37 AN 
- 23 inpatients 
- 14 outpatients 
15,2 - accelerometry 
- body fat assessment 
- leptin level 
- ghrelin level 
- start of therapy 
- end of therapy  
- one year follow up 
3 
consecutive 
days 
- influence of inpatients therapy on high levels of PA 
- consequences of high PA levels on physiological 
recovery 
 
- High level PA (HLPA) n=11, Low level PA 
(LLPA)  n=26 
- HLPA: age of onset earlier (duration of illness 
longer) 
- HLPA does not have a negative effect on 
recovery 
- PA normalizes during therapy 
- HLPA in the beginning of therapy has long-
standing consequences for recovery of body 
composition 
 
Hofmann et al., 
2014 
39 AN (divided in 
moderate and high 
activity group by median 
of steps) 
27,3 - Sense Wear Armband (biaxial 
accelerometer, heat flux, 
galvanic skin responses, skin 
temperature) 
- irisin plasma levels 
- energy expenditure 
calculated 
 
 
 
 
- inpatient treatment, 
not further defined 
3 
consecutive 
days 
- investigation of the relationship of circulation, irisin 
levels, PA levels, and energy expenditure in AN 
- no difference in irisin levels between the 
moderate and high activity groups 
- no association between irisin levels and 
various parameters of energy expenditure  
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El Ghoch et al., 
2013 
53 AN, 
53 age-matched controls 
24,5 - Sense Wear Armband 
(accelerometer) 
- first week of inpatient 
admission (baseline); 
last week of day-
hospital 
- end of treatment 
4 
consecutive 
days 
- assess role of PA on treatment outcome 
- compare AN patients and controls 
- Baseline: AN patients with higher moderate to 
vigorous PA (MVPA) than controls 
- Dropouts with higher MVPA (almost double) 
than completers 
 
- End of treatment: AN completers with higher 
number of steps, MVPA, and expenditure 
than controls 
- PA not correlated to ED psychopathology 
 
Alberti et al., 
2013 
52 AN 24,4 - Actiheart 
(Accelerometer+heart 
frequency)  
- IPAQ  
- second day of 
inpatient stay 
3 
consecutive 
days 
- comparison of subjective (IPAQ) and objective 
(AH) measurement of PA in AN 
- consequences for treatment outcome 
 
 
- IPAQ underestimates PA in comparison to AH  
- time spent in LPA > MVPA 
- higher levels of LPA at baseline associated in 
poorer improvement of ED pathology in the 
end 
Carrera et al., 
2012 
37 adolescent acute AN, 
(32 outpatients, 5 
inpatients) 
15,3 - Actiwatch (PA), right ankle 
- daily values for temperature 
from local meteorological 
stations (AT) 
- standardized measures of 
anxiety, depression, and ED 
 
- within first week of 
contacting ED center 
(outpatient) 
3 
consecutive 
days 
- assess the effect of ambient temperature on 
physical activity in acute AN 
- find other factors contributing to hyperactivity 
- cold group more active than warm group 
- AT has strongest correlation with PA 
(predictor of PA) 
- the more time spent in MVPA, the less 
anxiety 
Dellava et al., 
2012 
15 AN (recovered), 
18 healthy controls 
32,5 - ActiGraph  
- reasons for exercise 
inventory 
- food journals 
- food choice questionnaire 
- after 3 years without 
BMI under 17,5 nor 
engaging in binge 
eating or purging 
(outpatient) 
3 weekdays 
and 1 
weekend 
day 
- quantify PA, analyze diet and reasons for PA, and 
diet in women recovered from AN 
- find reasons for maintained lower BMI in recovered 
AN patients 
- BMI over two units lower in recovered women 
- macronutrient intake does not differ between 
both groups and is within normal ranges 
- reasons for food choices: recovered women 
select more for healthy benefits 
- no difference in PA between groups 
 
 
Bratland-Sanda, 
2010 
- 59 inpatients with 
long-standing ED 
(AN,BN,EDNOS) 
- 53 age-matched 
controls 
27,6 - ActiGraph (MTI Model) 
- VO2 max 
- muscular strength (Repetition 
maximum) 
- types of activity  
- Bone mineral density (BMD) 
- within first 2 weeks of 
inpatient stay 
7 
consecutive 
days 
- examine fitness, strength, BMD in inpatients with 
longstanding ED 
- associated and explanatory factors for BMD in 
inpatients 
- no difference in aerobic fitness between 
patients and controls despite PA higher in the 
patients 
- muscular strength and BMD lower in AN 
- muscular strength and high impact PA 
associated with BMD 
 
- strength training is preferable for AN and 
specialized exercise professionals should be 
included in the treatment staff 
- BMD screening! 
 
 
Bratland-Sanda 
et al., 2010 
38 longstanding ED (AN, 
BN, EDNOS), 
separated in excessive 
exerciser (EE) and non-
excessive exerciser 
(NEE) 
30,9 - Accelerometer (MTI 
ActiGraph), right hip  
- exercise dependence scale 
- reasons for exercise 
inventory 
 
 
 
 
 
 
 
 
 
- three times during the 
inpatient treatment 
period 
7 
consecutive 
days 
- analyze changes in PA on ex dependence during 
treatment 
- find correlation between PA, ex motivation, ex 
dependence, and ED divide in EE and NEE 
- divide in EE (Excessive Exercisers) and NEE (Non 
EE) 
- 29% were EE (classification of Davis et al.) 
- EE had higher EDI, Eating Disorder 
Examination (EDE), PA, ex dependence and 
importance of ex as affect regulation scores 
- reduction of PA positively correlated with EDI 
in whole sample 
- in EE reduced ED, psychopathology was 
correlated with   reduction in ex dependence 
and perceived importance of ex to regulate 
negative affects (excessive PA as affect 
regulation strategy) 
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Harris et al., 
2008 - eight AN, past weight 
restoration phase of 
illness 
- eight healthy controls 
36,0 - physical activity monitoring 
system (PAMS, 1,3kg), 
includes 4 inclinometers + 2 
accelerometers + calorimeter 
 
 
 
- outpatient 30 min 
resting 
(resting 
metabolic 
rate), 15 
min sitting, 
15 min 
standing, 
15 min 
walking 
- laboratory validation of PAMS  - PAMS showed sensitivity and specify in 
distinguishing lying, sitting, and standing 
- distinguished walking and standing still 
- correlation of acceleration with energy 
expenditure and walking velocity 
 
- PAMs seems to be a convincing technology 
of measuring PA in AN 
 
Hechler et al., 
2008 
- 10 AN, recovering 
- 15 healthy controls 
23,0 - Tracmor triaxial 
accelerometer, waist-worn 
- percent body fat (duel-energy 
x-ray absorptiometry)  
- outpatient 6 
consecutive 
days 
- find differences in PA between outpatients with AN 
and healthy controls 
- relationship between body fat and PA 
- measure PA in three seasons 
 
- groups did not differ in PA 
- seasonal variation in PA could be found in 
both groups: more engagement in summer 
- body fat  
- negative correlation between time spent in 
lean mass index and body fat in AN 
 
van Elburg et 
al., 2007 
18 AN inpatients 17,9 - Actiwatch on right ankle 
- Nurse rating on visual 
analogue scale (0-10) 
- Same scale as self-rating + 
profile of mood states 
 
- during inpatient 
treatment, not further 
defined 
3 
consecutive 
days 
- Compare self-report, Actometer, and nurse 
evaluation in PA evaluation of AN 
- nurse ratings correlate significantly with 
actometer score 
- self-reported activity underestimates 
actometer scores 
- PA ratings by nurses higher than by self-
rating on same score 
- Observation of hyperactivity made by nurses 
can be reliable and valid 
 
 
 
Klein et al.,2007 36 AN  26,3 - Sense Wear Armband, 
wireless device (82g), worn 
on upper arm (biaxial 
accelerometer+ sensor for 
heat flow+skin temp+galvanic 
skin responses) 
- CES 
- 24h - urine for cortisol 
- Between days 2 and 
14 of inpatient stay 
48 
consecutive 
hours  
- quantify PA in AN 
- association between exercise history and PA 
- association between cortisol and PA/ „drive for 
activity“? 
- 41.7% categorized as „high exerciser“ (Davis‘ 
categorization) 
- „high exercisers“ higher PA counts and higher 
scores in CES  
-> association between inpatient PA and pre-
hospitalization exercise behaviour (CES) 
- urinary cortisol positively associated with 
activity counts 
- no significant association between PA and 
affective psychopathology 
- categorization in „high exerciser“ makes 
sense 
 
 
Birmingham, 
2005 
17 AN 25,0 - triaxial accelerometer (RT3) 
- Beck Anxiety Inventory 
- within first 72 hours of 
inpatient admission 
48 hours  - find out if anxiety, cigarette smoking, or exercise 
contribute to caloric requirement for refeeding 
- no significant correlation between energy 
requirements for weight gain and anxiety, 
exercise, or cigarette smoking 
- standard methods of estimating caloric 
requirements for refeeding remain indirect 
calometry (Harris-Benedict-Equation) and 
previous history 
 
Holtkamp et al., 
2005 
26 acute AN 15,6 - Actiwatch, right ankle 
- Structured Interview for 
Anorexic and Bulimic 
Disorders (SIAB-EX) (3 
months before) 
- 5-point Likert scale for motor 
restlessness 
- visual analogue scale for 
inner restlessness 
- serum leptin 
- first 4 days of 
inpatient treatment 
4 
consecutive 
days 
- submit that leptin level and PA in AN have a 
negative correlation 
- relationship between leptin and various qualities of 
PA in acute AN 
- hypoleptinemia is a factor that leads to a 
variance of hyperactivity/restlessness in AN 
- relation between excessive ex over 3 months 
before treatment and PA in first 3 days of 
treatment 
- relation between motor and inner 
restlessness 
- U-shaped relation between mean daily activity 
and serum leptin (log10) 
- Therapy: administration of leptin 
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Westerterp et 
al., 1997 - 11 AN 
- 8 Obesity 
- 30 controls 
Not des-
cribed 
- Doubly labeled water (DLW, 
ADMR) combined with SMR 
(sleeping metabolic rate) 
- triaxial accelerometry 
(Tracmor, 110x70x35mm, 
250g) 
- 2 weeks of ADMR 
(inpatient stay) 
- first 7 consecutive 
days: Accelerometry 
7 
consecutive 
days 
- evaluate accelerometry with the DLW method (gold 
standard of PA assessment in 1997) 
- no significant difference between 
accelerometer PA levels and ADMR PA 
levels/64% of the variation in ADMR could be 
predicted in AN  
- overactivity in AN patients only occurs when 
BMI >17 
- Tracmor is a good device for daily PA 
assessment under free living conditions 
Bouten et al., 
1996 - 11 AN  
- 13 controls 
33,0 - DLW: PAL (ADMR/SMR 
(respiration chamber))  
- Accelerometry waist-worn 
(Tracmor, 16g device +250g 
data unit) 
 
 
- 7 consecutive days: 
Accelerometry 
(inpatient stay) 
- DLW on days 1 and 8 
7 
consecutive 
days (only 
waking 
hours) 
- comparison of level of daily PA in AN and normal 
weight controls 
- association PA and BMI 
- no difference in group average activity levels 
in AN and controls, but AN at either a low or a 
high level while controls at rather moderate 
level 
- metabolic rate lower in AN 
- high daily PA related to relatively high BMI in 
AN 
Kaye et al., 
1986 - 13 AN, recent weight 
rec  
- nine AN long-term 
weight rec 
- 11 controls 
 
25,0 - acceleration-sensitive device, 
waist worn 
- daily caloric intake (by 
kitchen) 
- 2-4 weeks after rec 
(first group) 
- 6 months after rec 
(second group) 
3 - 5 
consecutive 
days (with 
stable 
weight) 
- assessment of caloric consumption and activity 
levels in AN 
- comparison of recent weight recovered, long-term 
weight recovered AN and controls 
- Recent weight rec AN had significantly higher 
activity counts and caloric intake (kcal/kg/day) 
than long-term weight rec 
- treatment changes with graduated transition 
from hospital are important 
Falk et al., 1985 - 20 AN (divided into 3 
groups: cyproheptadine, 
amitriptyline, or placebo) 
21,1 - actometer (Timex model 108 
Motion Recorder, mechanical 
self-winding wristwatch) 
- Hamilton Rating score 
(depression) 
- Minnesota Multiphasic 
Personality Inventory 
- first 2 weeks of 
inpatient stay 
Four 
measureme
nts in 24 
hours 
(wake up, 
noon, 6 
PM, 
bedtime) 
 
 
- measurement of energy expenditure of inpatient 
women 
- relationship between motor activity, weight, drug 
administration, and behavioural assessment 
- activity increases during first two weeks of 
hospitalization along with weight gain 
- PA level is initially strongly suppressed by 
cyproheptadine 
- no relationship between activity level and 
depression score or personality 
 
AN: anorexia nervosa, ED: eating disorder, PA: physical activity, BMI: body mass index, HLPA: high level physical activity, MVPA: moderate to vigorous physical activity, BN: bulimia nervosa, EDNOS: eating disorder not otherwise 
specified, BMD: bone mineral density, IPAQ: International Physical Activity Questionnaire, LPA: low physical activity, AT: air temperature, EDI: Eating Disorder Inventory, CES, Commitment to Exercise Scale, ADMR: Average Daily 
Metabolic Rate, SMR: Sleep metabolic Rate, DLW: doubly labelled water, PAMS: physical activity monitoring system, AH: Actiheart 
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3.2 ANEX pilot study: Descriptive analysis of the samples 
3.2.1 Diagnosis and comorbidities 
Twenty-five women participated in the ANEX pilot study. Thirteen of them were 
classified as restrictive type AN, while 12 were classified as purging type AN as 
shown in Table 2. Using the inclusion criteria for the ANEX pilot study of 
subsyndromal AN (BMI<18.5 kg/𝑚2 ), 19 patients were diagnosed with AN 
(ICD10: F50.0), while four were diagnosed with subsyndromal anorexia nervosa 
and two patients were diagnosed with atypical anorexia nervosa (ICD10: 
F50.1). Twelve of the 25 participants were hospitalized at the inpatient unit of 
the Psychosomatic Department of the Tuebingen University Hospital, and they 
were defined as the inpatient group (IG). The same sample was assessed as 
the follow-up group (IG-FU) four weeks after inpatient treatment. Thirteen 
participants were outpatients at the Psychosomatic Department of the 
Tuebingen University Hospital (outpatient group - OG). Comparing the IG and 
OG, the mean BMI and the mean age were very similar (Table 2). The IG had a 
larger BMI range and a wider age range than the OG. The duration of illness 
was longer in the IG (9 years) than in the OG (6.7 years) indicating more 
complicated and more chronified cases of AN in the IG.  
 
Table 2: Type of anorexia nervosa, age, BMI and duration of illness in groups 
          OG (n=13) IG (n=12) 
Signifi-
cance 
(p) 
Restrictive AN n (%) 6 (46%) 7 (58%)   
Purging AN n (%) 7 (54%) 5 (42%)   
Age, mean ± SD (range) years 23.77 ± 3.70 (18-29) 24.83 ± 5.86 (18-40) 0.59 
BMI ± SD kg/𝒎𝟐 16.14 ± 2.02 (14-19) 15.04 ± 1.64 (13-19) 0.15 
Duration of illness in years 6.69 ± 3.73 9.00 ± 7.28  0.34 
 
AN: Anorexia nervosa, BMI: Body Mass Index, IG: inpatient group, OG: outpatient group, SD: standard deviation 
 
 
Most of the participants had one or more psychiatric or psychosomatic 
comorbidities, which are detailed in Table 3. Three patients had somatic 
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comorbidities: one had epilepsy, one had Wolff-Parkinson-White syndrome, and 
one patient had hypothyroidism.  
 
Table 3: Psychiatric comorbidities in the whole sample 
Comorbidity n (total) % 
depressive episode or recurrent depressive episode (F32/33) 16 72.7 
Mental and behavioural disorders due to 
psychoactive substance use (F10-19) 9 40.9 
Emotionally unstable personality disorder Borderline type (F60.31) 4 18.2 
Obsessive - compulsive disorder (F42) 4 18.2 
Persistent somatoform pain disorder (F45.4) 2 9.1 
Panic disorder (F41.0) 1 4.5 
Hyperkinetic disorder (F90.0) 1 4.5 
 
3.2.2 Physiologic parameters  
In the inpatient group laboratory parameters were measured as seen in Table 4. 
These values were measured at the beginning of inpatient treatment. This 
reduced selection of parameters was made because physiology was not the 
focus of this study.  
 
Table 4: Laboratory results in the inpatient group 
Laboratory Inpatient group normal value 
TSH ± SD (range) in mU/l 1.52 ± 0.90 (0.53-3) 0.4 – 2.5 
Red blood count ± SD (range) in Mio./μl 4.28 ± 0.64 (3.29 – 5.1) 4.0 – 5.4 
Hemoglobin ± SD (range) in g/dl 12.86 ± 1.49 (11-14.7) 12 - 16 
Leukocytes ± SD (range) per μl 5116.88 ± 1514 (2640-8220) 3800 - 10500 
TSH: thyroid stimulating hormone, SD: standard deviation 
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Additionally, all inpatients had an ECG during treatment time. The results are 
demonstrated in Table 5.  
 
Table 5: Electrocardiogram in the inpatient group 
ECG Inpatient group normal value 
QT interval ± SD (range) in % 113.18 ± 9.02 (100-130) 80 - 120  
Heart rate ± SD (range) 66.2 ± 12.21 (48-87) 
 
ECG: electrocardiogram, SD: standard deviation 
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3.2.3 Physical activity 
3.2.3.1 Accelerometry based physical activity assessment 
The wear time of the OG was 2797.36 ± 863.54 minutes on an average, which 
is about 11.66 hours per day on an average. Two patients had been wearing 
the ActiGraph for fewer than five hours and they were excluded from the 
analysis. The wear time of the IG was the longest: 3398.64 ± 519.54 minutes on 
an average, which is a mean wear time of 14.16 hours per day. At the follow-up 
measurement the mean wear time was 3293.33 ± 398.66 minutes which is 
about 13.72 hours per day. For all measurements the longest wear time was 
4180 minutes or 17.42 hours per day. The shortest wear time was 1093 minutes 
or 4.55 hours per day. The range of wear time was high, especially in the 
outpatients as seen in Figure 3.  
 
 
Figure 3: Mean daily wear time of the ActiGraph in groups 
OG: outpatient group, IG: inpatient group, IG_FU: inpatient group at follow-up 
 
                    
Figure 4 shows three outputs of objective PA assessment at the different 
measurement points: kcal per day, steps per minute, and counts per minute. 
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Time and percentage in the activity levels are shown separately (Figures 5 and 
6). Comparing the IG and the inpatient group at follow-up (IG_FU), kcal spent 
per day increased slightly after hospitalization. This was also the case for 
counts per minute. However, the number of steps per day decreased after 
hospitalization. The OG showed higher values than the IG in all three 
dimensions.  
 
 
Figure 4: Objectively measured physical activity by groups 
OG: outpatient group, IG: inpatient group, IG_FU: inpatient group at follow-up 
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As seen in Figure 5, the distribution of the PA into different levels only slightly 
differed between groups. The IG had the highest overall activity, which seems 
to be due to more time spent in LPA than the OG or the IG at follow-up. The IG 
also spent more hours in vigorous PA than OG and IG_FU (IG: 1.76 h/week; 
IG_FU: 0.88 h/week; OG: 1.10 h/week). The IG_FU spent the most hours of all 
three groups in moderate PA (IG_FU: 5.77; IG: 4.53; OG: 5.22).  
 
 
Figure 5: Distribution of wear time into different activity levels by groups 
OG: outpatient group, IG: inpatient group, IG_FU: inpatient group at follow-up, PA: physical activity  
 
The evaluation of the percentage of PA spent in moderate and vigorous and 
very vigorous PA (MVPA) showed a slight increase after treatment. The mean 
percentage of MVPA in IG was 7.35 ± 6.15% and the mean percentage of 
MVPA in IG_FU was 8.43 ± 5.28%. However, the OG had a higher mean 
percentage of MVPA than the IG and the IG_FU. The OG spent 8.75 ± 5.23% of 
their activity in MVPA (Figure 6).  
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Figure 6: Portion of ActiGraph wear time spent in MVPA by groups  
OG: outpatient group, IG: inpatient group, IG_FU: inpatient group at follow-up, MVPA: moderate to 
vigorous physical activity 
 
Additionally, the ActiGraph measured the average MET rate of the entire 
wearing period of each participant. The MET rate was defined as multiple of the 
basal metabolic rate. The OG had a mean MET rate of 1.20 ± 0.19 METs, the 
IG had a MET rate of 1.15 ± 0.20 METs, and the IG at follow-up had a MET rate 
of 1.21 ± 0.22 METs. This shows that the energy expenditure was slightly lower 
in the inpatient setting.  
3.2.3.2 Questionnaire based physical activity assessment 
a) International Physical Activity Questionnaire 
In the IPAQ the OG indicated more PA than the IG. The average number of 
reported hours per week in the IG was 12.23 ± 9.45 for walking hours, 1.70 ± 
1.92 for moderate hours and 2 ± 5.26 for vigorous hours. The OG reported to 
spend 15.27 ± 12.54 hours per week walking, 8.73 ± 10.21 hours per week in 
moderate physical activity (MPA), and 6.98 ± 9.78 hours per week in vigorous 
physical activity (VPA). The reported amount of vigorous PA was significantly 
higher in the OG (OG>IG: p<0.05). This is demonstrated in Figure 7.  
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Figure 7: Self-perceived distribution of time into different activity levels by groups  
Difference between OG and IG in walking hours: p=0.65, moderate physical activity: p=0.15 and vigorous 
physical activity: p=0.02* 
* = significance p<0.05 
OG: outpatient group, IG: inpatient group, IPAQ: International Physical Activity Questionnaire, PA: physical 
activity 
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Figure 8 shows that the mean percentage in MVPA was significantly higher in 
outpatients than inpatients. The average reported percentage of time spent in 
MVPA was 16.22 ± 19.60% in the IG and 45.84 ± 29.96% in the OG (OG>IG: 
p<0.05).  
 
 
Figure 8: Self-perceived percentage of time spent in MVPA by groups (assessed with the IPAQ) 
OG: outpatient group, IG: inpatient group, IPAQ: International Physical Activity Questionnaire, MVPA: moderate to 
vigorous physical activity  
 
As the results of the IPAQ can be converted into kilocalories per day, we also 
analyzed these data. The OG spent significantly more kilocalories per day 
compared to the IG (IG=317.99 kcal/day, OG 892.64 kcal/day; OG>IG: p<0.05). 
Figure 9 shows that the range of kilocalories per day was very high in all 
participants, especially in the OG.  
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Figure 9: Kilocalories per day by groups (assessed with the IPAQ) 
* = significance p<0.05 
OG: outpatient group, IG: inpatient group, IPAQ: International Physical Activity Questionnaire 
 
 
 
b) Commitment to Exercise Scale 
The OG showed higher commitment to exercise compared to the IG, while in 
the IG the range of the CES score was wider than in the OG (Table 6). CES 
was calculated on a 0 to 10 commitment score.  
 
 
Table 6: Results of the commitment to exercise scale in groups 
 
OG IG  significance 
CES score  6.76 ± 1.29  4.34 ± 2.48 OG > IG* 
* =significance p<0.05 
CES: Commitment to Exercise Scale, IG: inpatient group, OG: outpatient group 
 
 
 
The seventh item of the CES can be evaluated separately. It indicates feelings 
of guilt when an activity is omitted. Both groups, the IG and the OG, showed 
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high scores in CES-7 (Figure 10). The OG showed higher scores than the IG 
(OG: 8.05, IG: 6.01).  
 
 
Figure 10: Seventh item of the CES by groups – feelings of guilt when leaving out PA 
OG: outpatient group, IG: inpatient group, CES: Commitment to Exercise Scale, PA: physical activity 
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c) Reasons for Exercise Inventory: 
The Reasons for Exercise Inventory (REI) aims to find individual reasons for 
PA. Looking at the whole sample the most important reason for the 
performance of PA seemed to be “weight control” and “fitness,” while least 
important was “enjoyment.” “Weight control” was represented with the three 
statements: “I am physically active because I want to be slim,” “I am physically 
active because I want to lose weight,” and “I am physically active because I 
want to hold my actual weight.” For the IG “physical attractiveness” seemed to 
be least important as shown in Figure 11, while “fitness” was a very important 
reason for them to be active. Interestingly for both groups “mood” also seemed 
to be quite important with a score of around 5 out of 6 for the IG and OG 
(IG=4.82; IG=4.98). There were no differences in the reasons for exercise 
between the IG and OG. 
 
 
Figure 11: Reasons for Exercise Inventory results in groups 
REI: Reasons for Exercise Inventory, OG: outpatient group, IG: inpatient group 
 
Seventeen out of 25 patients stated in the sports questionnaire that they were 
doing one or more sports in their free time. Seven patients stated they did not 
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participate in any sports and one patient did not fill out the questionnaire. The 
different types of sports performed by the participants are shown in Table 7.  
 
Table 7: Types of sports activities in the whole sample 
sports n % 
running 9 40.91 
walking/hiking 6 27.27 
dancing 6 27.27 
cycling 4 18.18 
fitness/aerobic 2 9.09 
strength training 3 13.64 
swimming 2 9.09 
horse riding 2 9.09 
yoga 1 4.55 
playing the flute 1 4.55 
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3.2.4 ActiGraph and IPAQ in comparison 
The total amount of reported activity in the IPAQ was lower than the measured 
activity with the ActiGraph. The IG reported an overall activity of 15.93 hours 
per week in the IPAQ. With the ActiGraph, 84.38 hours per week were 
measured. The OG reported a total amount of 30.98 hours per week in the 
IPAQ, while 78.45 hours per week were measured with the ActiGraph. In 
comparison to the results of the accelerometer, the IPAQ showed a very high 
percentage of MVPA in both the IG and OG (Figure 12). Comparing the IG and 
OG, the difference between the results of the IPAQ and the results of the 
accelerometer was larger in the OG (IPAQ>ActiGraph: p=0.01).   
 
 
Figure 12: Comparison of objective (Actigraph) and subjective (IPAQ) assessment of MVPA 
between groups  
*= significance p<0.05 
OG: outpatient group, IG: inpatient group, IPAQ: International Physical Activity Questionnaire, %MVPA: percent of time 
in moderate to vigorous physical activity 
 
Comparing the kcal per day measured with the ActiGraph and the kcal per day 
measured by the IPAQ, the subjectively measured values were also higher than 
the objectively measured values (Figure 13). This was especially true for the 
OG (IPAQ>ActiGraph: p=0.02). Also, the between group difference was larger 
in the results of the IPAQ by comparison to the results of the accelerometer. 
0
5
10
15
20
25
30
35
40
45
50
OG IG
%
 M
V
P
A
Actigraph
IPAQp=0.01*
  51 
 
 
Figure 13: Comparison of subjective and objective measured energy consumption (kilocalories per 
day) between groups 
*= significance p<0.05 
OG: outpatient group, IG: inpatient group, IPAQ: International Physical Activity Questionnaire, kcal: kilocalories 
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3.2.5 Psychometric questionnaires 
3.2.5.1 Depression and perceived stress 
There was a notifiable difference between the OG and IG in the depression 
score of the PHQ (Patient Health Questionnaire) with high ranges in both 
groups (Table 8). However, both values were high representing serious 
symptoms of depression. Also the results of the PSQ showed high levels of 
stress in both groups. Comparing the two groups of participants, the largest 
effect between the OG and IG was the dimension of “joy” of the PSQ. The IG 
reported to have less joy than the OG, but also less worries than the OG.  
 
Table 8: PHQ and PSQ 
 
OG IG Significance (p) 
Effect size 
(Cohen's d) 
PHQ  
    
depression score ± SD 14.25 ± 5.19 16.42 ± 5.30 0.50 0.60 
PSQ -  subscales 
    
mean ± SD 0.58 ± 0.13 0.61 ± 0.16 0.43 0.29 
worries ± SD 0.66 ± 0.24 0.55 ± 0.19 0.34 -0.72 
tension ± SD 0.64 ± 0.19 0.72 ± 0.21 0.28 0.56 
joy ± SD 0.35 ± 0.20 0.23 ± 0.18 0.30 -0.89 
demand ± SD 0.34 ± 0.23 0.43 ± 0.17 0.24 0.63 
Effect size: d>0.8 = large effect, 0.5<d<0.8 = medium effect, 0.2<d<0.5 = small effect  
PHQ: Patients Health Questionnaire, PSQ: Perceived Stress Questionnaire, SD: standard deviation 
 
3.2.5.2 Eating disorder  
Restraint, eating concerns, weight concerns, and shape concerns revealed 
similar results in IG and OG. Taken together, the EDE (Eating Disorder 
Examination) total score indicated that the OG and IG did not differ in their 
extent of eating disorder pathology. The subscales of the EDI showed 
noticeable differences between the OG and IG, especially in the subscale 
“social insecurity,” where the IG scored significantly higher than the OG 
(IG>OG: p<0.05). Also, the mean scores of “body dissatisfaction,” 
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“ineffectiveness,” “interpersonal distrust,” and “interoceptive awareness,” were 
higher in the IG than in the OG. The subscales “perfectionism” and “maturity 
fears” were higher in the OG (Table 9). The two dimensions of the body image 
questionnaire (BIQ-20), the “Negative Evaluation of the Body” (NEB) and the 
“Perception of Body Dynamics” (PBD), were also shown in Table 9. There was 
an effect of the NEB when comparing the IG and OG (OG: 38.92; IG: 35.88). 
The PBD was 23.46 in the OG and 25.5 in the IG. Both, the results of the OG 
and the results of the IG indicate high rates of body image disturbances in the 
participants of this study. 
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Table 9: EDE, EDI and BIQ-20 
 
OG IG significance (p) Cohen's d 
EDE 
    restraint 3.65 ± 1.77 3.55 ± 1.84 0.71 -0.08 
eating concern 3.18 ± 1.61 3.20 ± 1.55 0.34 0.02 
weight concern 3.65 ± 1.52 3.58 ± 1.95 0.66 -0.06 
shape concern 4.41 ± 1.40 4.23 ± 1.46 0.55 -0.18 
total 3.73 ± 1.47 3.64 ± 1.49 0.54 -0.09 
     EDI 
    drive for thinness 30.09 ± 9.16 29.41 ± 11.14 0.8 -0.09 
bulimia 16.36 ± 7.05 17.42 ± 8.54 0.71 0.19 
body dissatisfaction 35.36 ± 11.20 41.75 ± 6.94 0.4 0.97 
ineffectiveness 35.55 ± 8.71 40.83 ± 6.13 0.21 0.99 
perfectionism 22.27 ± 3.82 20.58 ± 5.55 0.96 -0.5 
interpersonal distrust 21.27 ± 7.58 26.41 ± 5.85 0.08 1.0 
interoceptive awareness 35.18 ± 5.42 41.16 ± 8.72 0.1 1.16 
maturity fears 26.82 ± 4.29 23.16 ± 6.55 0.23 -0.93 
asceticism 26.09 ± 7.31 27.58 ± 5.65 0.98 0.32 
impulse regulation 28.27 ± 4,94 27.33 ± 7.10 0.77 -0.22 
social insecurity 26.27 ± 5.14 30.50 ± 5.70 0.02* 1.1 
mean score 303.55 ± 28.20 326.17 ± 51.09 0.24 0.78 
     BIQ-20 
    NEB (dimension 1) 38.92 ± 9.55 35.88 ± 6.71 0.327 -0.52 
PBD (dimension 2) 23.46 ± 7.26 25.5 ± 6.46 0.562 0.42 
* = significance p<0.05; effect size: d>0.8 = large effect, 0.5<d<0.8 = medium effect, 0.2<d<0.5 = small effect 
OG: outpatient group, IG: inpatient group, EDE: Eating Disorder Examination Questionnaire, EDI: Eating disorder 
Inventory, BIQ: Body Image Questionnaire, NEB: negative evaluation of the body, PBD: perception of body dynamics 
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3.3 ANEX pilot study: Correlates of physical activity 
3.3.1 Commitment to exercise  
The subjective importance of physical activity was measured with the 
Commitment to Exercise Scale (CES). The seventh item of the CES represents 
feelings of guilt when skipping a sports activity. CES_07 correlated significantly 
with accelerometry assessed PA parameters in all samples of the study (Table 
10). Especially in the IG at follow-up, the CES_07 correlated significantly with 
the time spent in vigorous physical activity (VPA) (p<0.01, r=0.791). In the same 
sample there was a significant negative correlation between the CES_07 and 
the time spent in low physical activity (LPA) (p<0.01, r=-0.848). Moreover, 
CES_07 correlated significantly with the time spent in moderate physical activity 
(MPA) in the OG (p<0.05, r=0.721) and with the time spent in VPA in the IG 
(p<0.05, r=0.691). A compilation of all correlations between commitment to 
exercise and objectively measured PA parameters is provided in the appendix. 
 
Table 10: Correlation of the seventh item of the CES (feelings of guilt) with objectively measured 
physical activity parameters in groups 
correlation 
 
all OG IG IG_FU 
CES_07 with LPA r -0.319 -0.370 -0.134 -0.848** 
 
p 0.212 0.293 0.730 0.002 
CES_07 with MPA r 0.263 0.721* 0.227 0.049 
 
p 0.309 0.019 0.557 0.894 
CES_07 with VPA r 0.285 -0.122 0.691* 0.791** 
 
p 0.252 0.737 0.039 0.006 
CES_07 with MVPA % r 0.333 0.636* 0.391 0.494 
 
p 0.177 0.048 0.263 0.147 
*= significance p<0.05 
*= significance p<0.01 
CES_07: seventh item of the Commitment to Exercise Scale – feelings of guilt when leaving out physical activity, OG: 
outpatient group, IG: inpatient group, IG_FU: inpatient group at follow-up, PA: physical activity LPA: light physical 
activity, MPA: moderate physical activity, VPA: vigorous physical activity, r: correlation coefficient
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3.3.2 Reasons for exercise 
Weight control as a reason for PA correlated significantly with objectively 
measured PA. Interestingly in the OG the correlation with percent of time in 
moderate to vigorous PA (MVPA) was positive, while in the IG, weight control 
as a reason for exercise correlated significantly negative with the percent of 
time in MVPA. In the IG there was a significantly positive correlation between 
health as a reason for exercise with steps/min (p<0.05, r=0.821), CPM (p<0.05, 
r=0.815) and especially percent in MVPA (p<0.01, r=0.883). In the OG no 
strong correlations were found; however, all of them were negative.  Details of 
the correlations between reasons for exercise and objectively measured PA 
parameters can be found in the appendix.  
Fitness, mood, physical attractiveness and tone as reasons for exercise did not 
correlate significantly with accelerometer assessed PA parameters. In the OG 
enjoyment as a reason for exercise correlated significantly negative with the 
time spent in low level PA (LPA). This is shown in Figure 14. 
 
 
Figure 14: Correlation of enjoyment as reason for exercise and objectively measured time in LPA in 
the outpatient group 
LPA: light physical activity, h/week: hours per week 
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3.3.3 Body image 
There were only weak correlations between objectively measured PA and the 
first dimension of the Body Image Questionnaire (BIQ), “negative evaluation of 
the body” (NEB). The second dimension, “perception of body dynamics” (PBD) 
correlated significantly with counts per minute (CPM) in the OG (p<0.05, 
r=0.647). Additionally, PBD and the time spent in vigorous PA (VPA) correlated 
significantly in the OG (p<0.05, r=0.689). In the IG, PBD correlated significantly 
with the percent of time spent in moderate to vigorous PA (MVPA). In the whole 
sample there was a significant correlation between dimension 2 (PBD) of the 
BIQ and CPM (p<0.01, r=0.584). This is shown in Table 12. More correlations 
between body image and objectively measured PA parameters can be found in 
the appendix. 
 
Table 11: Correlation of perception of body dynamics (PBD) with objectively measured physical 
activity parameters 
correlation   all OG IG IG_FU 
BIQ-20 (PBD) with CPM r 0.584** 0.647* 0.551 0.335 
 
p 0.009 0.031 0.157 0.417 
BIQ-20 (PBD) with MVPA % r 0.506* 0.287 0.753* 0.551 
 
p 0.027 0.392 0.031 0.157 
* = significance <0.05,  
** = significance<0.05 
OG: outpatient group, IG: inpatient group, IG_FU: Inpatient group at follow-up, BIQ: Body Image Questionnaire, 
PBD: perception of body dynamics, CPM: counts per minute, VPA: vigorous physical activity, MVPA%: percent of 
time spent in moderate to vigorous physical activity, r: correlation coefficient 
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3.3.4 Depression 
Figure 15 demonstrates a significant correlation between the depression score 
of the PHQ and the accelerometer assessed counts per minute (CPM) in the 
whole sample (p<0.5, r=-0.514). 
 
 
Figure 15: Correlation of depression (PHQ) and objectively measured counts per minute in all 
participants 
PHQ: Patient Health Questionnaire 
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3.3.5 Stress 
There was a significant correlation between the PSQ mean scale and the 
percent of time spent in MVPA (p<0.01, r=0.568) in the full sample. There was 
also a significantly negative correlation between worries as an item of the PSQ 
and time spent in VPA, especially in the OG (p<0.01, r=-0.788) and in the whole 
sample (p<0.01, r=-0.606), but also in the IG (p<0.05, r=-0.739). Additionally, in 
the OG and in the full sample there was a significant correlation between 
worries and steps per minute (whole sample: p<0.5, r=-0.451; OG: p<0.05, r=-
0.635) and between worries and percent of time in MVPA (whole sample: 
p<0.05, r=-0.527; OG: p<0.05, r=-0.702). A significant positive correlation was 
found between joy as an item of the PSQ and objectively measured PA: joy and 
steps per minute correlated significantly in the whole sample (p<0.05, r=0.473), 
in the IG (p<0.01, r=0.852) and in the IG_FU (p<0.01, r=0.813). Joy and time 
spent in MPA correlated significantly in the whole sample (p<0.05, r=0.434), in 
the IG (p<0.05, r=0.787), and especially in the IG_FU (p<0.01, r=0.815). An 
overview of all correlations of worries and joy with different PA parameters in 
the different samples can be found in Tables 13 and 14. A more detailed 
compilation of PSQ parameters and objectively measured PA parameters can 
be found in the appendix. 
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Table 12: Correlation of worries (PSQ) with objectively measured physical activity parameters 
correlation 
 
all OG IG IG_FU 
worries with steps/minute r -0.451* -0.635* -0.391 -0.447 
 
p 0.040 0.049 0.299 0.227 
worries with MPA (h/week) r -0.178 -0.347 -0.209 -0.344 
 
p 0.441 0.326 0.620 0.365 
worries with VPA (h/week) r -0.606** -0.788** -0.739* -0.622 
 
p 0.004 0.007 0.036 0.074 
worries with MVPA % r -0.527* -0.702* -0.547 -0.506 
 
p 0.014 0.024 0.128 0.165 
 
 
* = significance <0.05,  
** = significance<0.05, 
OG: outpatient group, IG: inpatient group, IG_FU: Inpatient group at follow-up, PSQ: Perceived Stress Questionnaire, 
MPA: moderate physical activity, VPA: vigorous physical activity, MVPA%: percent of time spent in moderate to 
vigorous physical activity, r: correlation coefficient 
 
Table 13: Correlation of joy (PSQ) with objectively measured physical activity parameters 
correlation 
 
all OG IG IG_FU 
joy with steps/minute r 0.437* 0.090 0.852** 0.813** 
 
p 0.048 0.804 0.004 0.008 
joy with MPA (h/week) r 0.434* -0.041 0.787* 0.815** 
 
p 0.050 0.910 0.020 0.007 
joy with VPA (h/week) r 0.338 0.360 0.817* 0.786* 
 
p 0.134 0.307 0.013 0.012 
joy with MVPA % r 0.456* 0.142 0.865** 0.790* 
 
p 0.038 0.696 0.003 0.011 
* = significance <0.05,  
** = significance<0.05, 
OG: outpatient group, IG: inpatient group, IG_FU: Inpatient group at follow-up, PSQ: Perceived Stress Questionnaire, 
MPA: moderate physical activity, VPA: vigorous physical activity, MVPA%: percent of time spent in moderate to 
vigorous physical activity, r: correlation coefficient 
 
3.3.6 Eating behavior  
In the whole sample, taking all participants of all groups together, there was a 
positive correlation of weight concern as an item of the EDE with PA 
parameters (Table 15): Counts per minute (CPM) correlated significantly with 
weight concern (p<0.5, r=0.045) and time spent in vigorous PA (VPA) also 
correlated significantly with weight concern (p<0.01, r=-0.626). In the IG a 
significant correlation between weight concern and VPA was found (p<0.05, r=-
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0.772). There were two significant correlations between shape concern and PA 
in the full sample: CPM correlated significantly with shape concern (p<0.05, r=-
0.520) and time spent in VPA correlated significantly with shape concern, too 
(p<0.01, r=-0.611). Additionally, there was a significant correlation between 
shape concern and time spent in VPA in the IG (p<0.05, r=-0.730). There was 
no correlation of any item of the EDE with any PA parameter in the IG at follow-
up (Table 15). 
 
Table 14: Correlation of weight concern and shape concern (EDE) with objectively measured 
physical activity parameters in groups 
correlation 
 
all OG IG IG_FU 
Weight concern with CPM r -0.441* -0.308 -0.521 -0.595 
 
p 0.045 0.421 0.150 0.091 
Weight concern with VPA (h/week) r -0.626** -0.433 -0.772* -0.534 
 
p 0.002 0.245 0.025 0.139 
Shape concern with CPM r -0.520* -0.619 -0.222 -0.067 
 
p 0.016 0.075 0.566 0.864 
Shape concern with VPA (h/week) r -0.611** -0.730* -0.506 -0.328 
 
p 0.003 0.025 0.200 0.388 
* = significance <0.05,  
** = significance<0.05, 
EDE: Eating disorder Examination, OG: outpatient group, IG: inpatient group, IG_FU: Inpatient group at follow-up, CPM: 
counts per minute, VPA: vigorous physical activity, r: correlation coefficient 
 
Social insecurity as an item of the Eating Disorder Inventory (EDI) and objective 
PA parameters interrelated variously in the OG. CPM correlated significantly 
negative with social insecurity (p<0.05, r=-0.769) and time spent in VPA 
correlated significantly with social insecurity (p<0.05, r=-0.702). In the whole 
sample there was a significant negative correlation between ineffectiveness as 
an item of the EDI and CPM (p<0.05, r=-0.486). This negative correlation 
between ineffectiveness and CPM also appeared in the OG (p<0.05, r=-0.687). 
Moreover, there was a significant correlation between ineffectiveness and time 
spent in VPA in the OG (p<0.05, r=-0.680). There could not be found any 
correlation between EDI items and accelerometry assessed PA parameters in 
the IG and in the IG at follow-up. A table with an overview of relevant 
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correlations between social insecurity and ineffectiveness (EDI) and objectively 
measured physical activity parameters can be found in the appendix. 
3.4 Refusals, dropouts and missing data 
During the ANEX pilot study 47 female patients with AN were introduced to the 
study. They were all patients at the Department of Psychosomatic Medicine and 
Psychotherapy at the University of Tuebingen. All of the 47 patients filled out 
PSQ, PHQ, EDI and the EDE and they all were registered with age, BMI and 
duration of illness. All patients that refused to participate were asked for their 
reasons. Reported reasons for refusal were mainly: 
 
- Too much stress in general  
- Fear of observation 
- Feeling of pressure while wearing the accelerometer device  
- That the instructor could think that the patient was lazy if there was not 
measured enough activity with the ActiGraph (this was the case even if the 
instructor explained that the amount of activity was not relevant)  
- Fear that the ActiGraph would control them  
- Patients did not want to talk about their reason for refusal  
- patients were injured and stated that an activity measurement would not make 
sense   
 
Twenty-five of the 47 females decided to take part in the ANEX pilot study. Two 
of the 25 participants dropped out during the process of the study, because they 
were stressed too much by wearing the ActiGraph. They reported that they had 
to think about the device all the time and that it was uncomfortable to wear. Two 
patients lost their accelerometer device and never found it again, so that 
measurement had to be repeated. One patient was extremely ambivalent. She 
decided not to participate on the first day and contacted the instructor on the 
next day because she wanted to participate. One day later she decided again 
not to participate. The instructor let her time to think. Finally, she participated. 
The process of inclusion including dropouts, refusals, and reasons for missing 
data is demonstrated in Figure 16.  
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Figure 16: Process of study inclusion with study refusals, dropouts and missing data 
AN: Anorexia nervosa, OG: outpatient group, IG: inpatient group 
 
Comparing characteristics of study participants and study refusals, the mean 
BMI and the mean age were similar, while the duration of illness was slightly 
longer in the study participants (Table 16). 
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Table 15: BMI, age and duration of illness in study participants and study refusals 
 
study participants 
(whole sample) study refusals significance (p) 
BMI ± SD 15.81 ± 1.93 15.35 ± 1.79 0.44 
Age (years) ± SD 24.09 ± 4.98 24.57 ± 8.00 0.81 
 
Duration of illness  
(years) ± SD 7.82 ± 5.93 5.91 ± 5.38 0.27 
 
BMI: Body Mass Index, SD: standard deviation 
 
The graduation level was higher in the study participants. Study participants 
had more university degrees and high school degrees (Figure 17). 
 
 
Figure 17: Percentage of the groups at different graduation levels 
 
The depression score of the PHQ also indicated similar values in the study 
participants and the study refusals as to be seen in Table 17. The perceived 
stress was higher in the study refusals. The worries were stated to be especially 
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higher in study refusals and they reported less joy than the participants. The 
results of the PSQ with the four dimensions “worries,” “tension,” “joy,” and 
“demand” are shown in Table 17.  
 
Table 16: PHQ and PSQ in study participants and study refusals 
 
study participants 
(whole sample) study refusals 
significance 
(p) 
effect size 
(Cohen's d) 
PHQ 
    depression score  15.25 ± 5.68 15.74 ± 7.17 0.81 -0.11 
     PSQ 
    Mean  0.59 ± 0.15 0.66 ± 0.19 0.17 -0.58 
worries 0.60 ± 0.24 0.73 ± 0.28 0.10 -0.71 
tension 0.67 ± 0.21 0.71 ± 0.28 0.61 -0.23 
joy 0.31 ± 0.20 0.22 ± 0.18 0.14 0.67 
demand 0.38 ± 0.22 0.39 ± 0.21 0.94 -0.07 
 
 
effect size: d>0.8 = large effect, 0.5<d<0.8 = medium effect, 0.2<d<0.5 = small effect 
PHQ: Patient Health Questionnaire, PSQ: Perceived Stress Questionnaire 
 
Comparing the eating disorder questionnaires, study participants and study 
refusals had similar results. This is demonstrated in Table 18. 
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Table 17: EDE and EDI in study participants and study refusals 
 
study participants study refusals 
Signifi- 
cance (p) 
effect size 
(Cohen's d) 
EDE 
    
restraint 3.21 ± 1.89 3.79 ± 2.06 0.37 -0.41 
eating concern 2.86 ± 1.69 3.54 ± 1.70 0.22 -0.57 
weight concern 3.4 ± 1.67 4.26 ± 1.42 0.92 -0.78 
shape concern 3.94 ± 1.62 4.54 ± 1.47 0.23 -0.55 
total 3.37 ± 1.53 4.03 ± 1.54 0.19 -0.61 
     
EDI 
    
drive for thinness 29.11 ± 10.66 28.28 ± 12.72 0.83 0.10 
bulimia 15.95 ± 7.69 17.50 ± 10.87 0.62 -0.23 
body dissatisfaction 37.37 ± 9.93 37.78 ± 11.59 0.91 -0.05 
ineffectiveness 37.47 ± 8.20 38.78 ±11.73 0.70 -0.18 
perfectionism 22.26 ± 4.65 19.17 ± 6.01 0.09 0.81 
interpersonal distrust 23.63 ± 7.51 23.89 ± 5.83 0.91 -0.05 
interoceptive awareness 37.32 ± 8.23 36.89 ± 10.65 0.89 0.06 
maturity fears 24.84 ± 6.18 27.78 ± 7.34 0.20 -0.61 
asceticism 26.53 ± 6.74 24.72 ± 5.59 0.38 0.27 
impulse regulation 27.53 ± 5.89 29.44 ± 7.64 0.40 -0.40 
social insecurity 28.31 ± 6.24 29.22 ± 7.05 0.68 -0.19 
mean score 310.32 ± 48.99 313.44 ± 67.98 0.87 -0.07 
 
effect size: d>0.8 = large effect, 0.5<d<0.8 = medium effect, 0.2<d<0.5 = small effect 
EDE: Eating Disorder Inventory, EDI: Eating Disorder Examination 
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4 DISCUSSION 
The aim of this thesis was the establishment of accelerometry as a method to 
measure physical activity (PA) in anorexia nervosa (AN) and the assessment of 
its feasibility. In a systematic review all previous studies using accelerometry in 
AN were included. Subsequently, in the ANEX pilot study physical activity was 
measured objectively with the ActiGraph. This is the first study that uses several 
different output parameters of accelerometry to make statements not only about 
the quantity of activity, but also about the levels of activity. It also makes it 
possible to compare the results with diverse previous data of PA assessments 
in AN (Gummer et al., 2015) Given the fact that study refusals occurred 
frequently in this study and in similar previous studies (Bratland-Sanda et al., 
2010) (Bratland Sanda et al., 2010b) (Keyes et al., 2015), this is a reflection of 
and provides insight into the background of PA in AN. So not only objective PA 
and self-perceived PA, but also commitment to exercise, reasons for exercise, 
eating disorder and general psychopathology were measured in outpatients and 
in inpatients. The inpatient group performed a second measurement one month 
after their discharge from the hospital. Thus, the development of PA after 
hospitalization could also be analyzed.  
 
4.1 Establishment of accelerometry in anorexia nervosa 
For the establishment of accelerometry as a standard method of PA 
assessment in AN an overview of the literature was made: 
“In this first systematic review about PA measurement with accelerometry in 
AN, 20 studies were identified. The study populations consisted of females with 
an average mean BMI of 16.4 kg/m² and an average age of 24.4 years. Study 
population size varied from 8 to 59 women. PA assessment was fulfilled by 
different types of accelerometry devices, in most trials combined with 
questionnaires or further experimental measurements like ambient temperature, 
bone mineral density, or metabolic rate. Mean duration of PA assessment was 
4.5 consecutive days. Most studies included one single PA measurement in the 
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first week of inpatient treatment, but the studies varied a lot with regard to the 
time of assessment. Purposes and results of the included studies appear 
heterogeneous, due to differing paradigms and outcomes within heterogeneous 
samples. Since some studies included only very few participants with 
consequential statistical limitations, statements have to be discussed 
conservatively. We therefore clustered the studies into five different groups. The 
first cluster of studies mainly concerned methodology, more precisely the 
validation of accelerometry in general or the comparison of accelerometry with 
other methods. These trials showed that accelerometry is a valid and reliable 
method of PA assessment in AN. The second cluster concentrated on the 
comparison of PA quantity in either AN and healthy controls, or in high and low 
exercising AN. They showed that AN had higher PA levels than healthy controls 
and that high exercising AN patients had more severe psychopathology, but the 
findings are contradictory. The third cluster discusses studies including women 
who have recovered from AN. These studies indicate that PA level stays 
abnormal for about half a year after recovery. The fourth cluster of studies 
aimed at finding reasons for HLPA in AN and found that hormones like cortisol 
or leptin, BMI, or the ambient temperature may play a role. The fifth cluster of 
studies focused on the treatment to find how PA interacted with therapy. 
Studies from different groups additionally investigated psychopathology, where 
the results were conflictive about whether or not ED psychopathology and PA 
levels were associated.  
Although it is not possible to draw a synthesis of all studies included in this 
review, we tried to find generally valid statements concerning PA in AN.” 
(Gummer et al., 2015)  
4.1.1 Segmentation of the study population 
“Concerning the sample characteristics, a segmentation of the study population 
into a high and a low exercise type, as presented in four studies of this review, 
should be discussed (Turner, Bryant-Waugh, & Peveler, 2009). It seems that 
high-exercisers need different key aspects in their treatment and longer support 
and supervision after inpatient therapy (K. Giel et al., 2013). With respect to 
this, it would make sense to define common criteria for a HLPA subtype of AN 
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and a common terminology for that subtype. As this classification should be 
used in a daily clinical context, it would be reasonable to utilize a simple tool, 
such as that as proposed by Zipfel et al. (2013). The Eating Disorder Inventory 
(EDI-SC) item ‘What percentage of your exercise is aimed at controlling your 
weight?’ was used to distinguish between high-level and low-level exercisers by 
using a cut-off set at < 50%. Another classification suggested by Davis et al. 
(1997), taking into account the accelerometry output, implies that an objective 
PA assessment becomes standard therapy in AN, which is already 
implemented in some ED centers. With knowledge about HLPA, this 
dysfunctional behavior can be addressed in cognitive-behavioral interventions, 
integrated in a background of eating behavior, and can affect regulation and 
personality (perfectionism, rigidity, or obsessive-compulsive traits, etc.). 
Additionally, physical therapy regarding HLPA should be part of a special 
treatment for AN patients with HLPA.” (Gummer et al., 2015) 
4.1.2 Evaluation of devices 
“Concerning PA assessment, accelerometry is the most user-friendly method to 
objectively measure PA in AN. There are many slightly different types of 
validated accelerometers used in the studies. One type of accelerometer, for 
example, measures the heart frequency besides the triaxial accelerometry so 
that it can be seen when the study participant does not wear it. The 
disadvantage of this device is the usability and wearing comfort, because it has 
to be attached to the breast, which can again result in worse compliance of the 
participant. This is also true for a type of accelerometer armband, which 
additionally measures galvanic skin responses, heat flux, and skin temperature 
and gives clues when the participant does not wear the device. This can be 
important information, especially in inactive participants, because accelerometry 
is not able to distinguish between a person that does not move and a device 
that lies next to a person. The advantages of devices that only measure 
accelerometry are weight, price, and wearing comfort.” (Gummer et al., 2015) 
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4.1.3 Categorization of activity levels 
“The categorization of activity levels in AN is sparsely described in the studies 
and varies greatly. A generally accepted validated categorization of Sedentary 
PA, Low PA, and MVPA (moderate-vigorous physical activity) should get 
established with regard to the fact that devices can be worn as an armband, on 
the waist, or on the ankle. Proposals for classification have been made by 
Bouten et al. (1996), Bratland Sanda et al. (2010) and Kostrzewa et al. (2013).” 
(Gummer et al., 2015) 
4.1.4 Combination of methods 
“A combination of accelerometry and activity diaries, as well as activity 
questionnaires, like CES, is important. Subjective PA assessment 
underestimates PA in AN, shown by El Ghoch (2013) and van Elburg (2007). 
An additional item can be a nurse evaluation, as shown by van Elburg (2007). 
With such a combination of items, misuse of accelerometry or underestimating 
questionnaires can be detected.” One method that helps in this context is the 
DLW technique, because it cannot be influenced by the participant and offers 
exact values of basal metabolic rate and total daily energy expenditure. The 
disadvantage of not providing activity patterns in time can be eliminated by 
combining it with accelerometry. DLW in combination with accelerometry would 
be the most exact PA assessment method in AN; however, to our knowledge 
this combination has not been used.” (Gummer et al., 2015) 
4.1.5 Treatment and recovery 
“The time of assessment in the investigated studies was mostly in the first week 
of inpatient treatment, and in most trials only once. To get an idea of how 
treatment interferes with levels of PA in AN and to get to know how treatment 
has to be changed for adequate recovery rates (as well as in patients with 
HLPA), data with more than one PA measurement is needed. Measurements 
before the start of a treatment are especially required, which, to our knowledge, 
have not been fulfilled at all. More studies comparing PA between outpatients 
and inpatients would also be important to find out how inpatient treatment 
contributes to HLPA (Keyes et al., 2015). There is evidence (Kaye et al., 1986) 
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that weight gain in inpatient settings goes along with increased levels of PA, 
which could be assumed as a purging behavior to control weight during 
refeeding. However, there is considerable evidence to suggest that problematic 
exercise in the eating disorders is not just determined by weight control 
methods; aspects such as rigidity, compulsivity, and affect regulation are also 
important features that must be addressed (Meyer, Taranis, Goodwin & 
Haycraft, 2011). 
Treatment of AN could often be modified in a way that patients with HLPA are 
also treated adequately. The study of Kostrzewa et al. (2013) has to be taken 
into account. They found that there were greater changes in body composition 
in HLPA patients with AN, meaning that fat tissue tend to grow faster in 
abdominal regions than at the extremities, which could be an understandable 
reason for treatment dropout or relapse, and should be a therapy issue (Giel et 
al., 2013). 
Important for the modification of treatments would also be the physiological 
factors discussed in some studies of this review. Hypoleptinemia is associated 
with HLPA. The administration of leptin has been successful in rats (Exner et 
al., 2000). As hypercortisolism and PA levels also seem to interfere, cortisol-
antagonists are discussed, but, to our knowledge, have never been tried in 
humans. 
 In the two studies with recovered AN patients it can be seen that HLPA is still 
an issue after recovery, which implies that it is important to supervise those 
patients and make follow-up examinations (Giel et al., 2013). As muscle 
strength interferes with physical fitness and BMD in AN, a training program with 
specialized exercise professionals could be a helpful supplement in the 
treatment and improve outcomes. A good example of a high-intensive 
resistance training program is presented by Fernandez-del-Valle et al. (2014)” 
(Gummer et al., 2015) 
4.1.6 Psychopathology 
“The relation between psychopathology and levels of PA is controversially 
discussed. Further research is needed to objectively compare measured PA 
levels in AN with features like ED psychopathology, anxiety scores, and 
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personality (Keyes et al., 2015). This can help in understanding the 
psychological background of PA in AN, if HLPA is a method of regulating 
negative effects or anxiety or a result of a compulsive personality trait (Lloyd, 
Fleming, Schmidt, & Tchanturia, 2014).” (Gummer et al., 2015) 
4.1.7 Dropouts 
“What attracts attention regarding the study population is the number of 
dropouts. This arose mainly because of missing data from the accelerometer 
(also in more recent studies), showing that the accelerometer technique can still 
be improved and the choice of the accelerometer should be made carefully, 
even if differences between the devices are not crucial (Trost et al., 2005). 
Missing data from a device not only includes malfunction of the device itself, but 
also misuse of the device by the participant; how the missing data came about 
cannot always be detected afterwards. Five authors describe cases of not 
enough wear time or even no wear time at all. Bratland-Sanda et al. (2010) 
mention consecutive patients that even refused participation. Regarding those 
results and having problematic experiences with refusal and compliance around 
PA assessment, we propose that objective PA assessment in AN has not yet 
been discussed in a comprehensive way. It seems remarkable that not even 
half of the discussed trials of this review mention problems with refusal or 
compliance, while the rest does not mention this topic at all. We assume that 
wearing an accelerometer device represents a big problem for some patients 
with AN, especially in an inpatient setting, because it seems to constrain 
autonomy. Patients with AN show high needs for autonomy, which is already 
constrained in inpatient setting because eating behaviour is observed closely. 
So PA behaviour remains one behaviour that can hardly be controlled by 
anyone. This could make it more difficult to recruit participants for studies and 
also understandable as to why patients misuse the devices. Furthermore, it 
proves the high importance of PA for patients with AN.” (Gummer et al., 2015)  
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4.2 ANEX: Presentation and interpretation of the results 
4.2.1 Alignment of the physical activity data  
The World Health Organizations (WHO) global recommendation for health of 
adults indicates that everyone should perform 150 minutes of moderate PA per 
week or 75 minutes of vigorous PA per week or any equivalent combination of 
both activity levels. In our study the participants performed between 4.53 hours 
and 5.77 hours per week in moderate PA which is around 300 minutes per 
week in moderate PA and 0.88 to 1.76 hours in vigorous PA, which equates to 
around 60 minutes per week. Taken together the patients of our study seem to 
perform more than enough PA according to the WHO recommendations. 
The Robert-Koch-Institute found in a survey that only 18.4% of healthy German 
females aged 18 to 29 years performed more than 2.5 hours of moderate to 
vigorous PA (MVPA) per week (Krug et al., 2013). Performing five or more 
hours of MVPA per week on an average, the participants of our study seem to 
be more active than the average age matched German healthy female. These 
data are based on subjective PA assessments. Unfortunately, there is not much 
objectively assessed data about PA in healthy individuals (Loyen et al., 2016). 
“Objective data of adults across Europe is currently limited.” (Loyen et al., 2016) 
However, two studies assessed PA with the help of accelerometry: Cerin et al. 
(2014) performed a cross-sectional study in countries all over the world and 
found that people in Baltimore, USA, are the least physically active. They 
performed 25 minutes of MVPA per day, on an average. People in Christchurch, 
New Zealand were the most active with almost 50 minutes of MVPA per day. 
Similar results of accelerometry-based PA assessment in healthy individuals 
have been published by van Dyck et al. (2015) who measured an MVPA of 36 
minutes/day as an average of measurements at ten different sites throughout 
the world. Also in that study, the amount of time in MVPA varied significantly 
from 29.2 minutes per day in the USA up to 51.0 minutes per day in Spain. 
Participants in the ANEX pilot study performed a mean of 50 minutes of MVPA 
per day. This shows again that, on an average, the participants of this study 
were more active than most healthy individuals.  
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Comparing objectively measured PA levels of this study with accelerometer 
assessed activity levels in patients with AN, a detailed compilation of the 
individual accelerometer outputs can be seen in Table 19. In comparison to all 
previous studies the participants of this study have a high, but not excessively 
high, level of PA. Comparison of PA has to be made very carefully because of 
different devices, different outputs, and different units. The output that has been 
used most frequently in the past was counts per minute (CPM). The percent or 
time in MVPA has also been used often, while steps, kcal and metabolic 
equivalents (METs) have been only used once or twice. Keyes et al. (2015) 
measured significantly lower counts per day in outpatients with AN than we did 
(Keyes: 249.73 CPM; ANEX: 693 CPM). It is not possible to compare those two 
values, because Keyes et al. (2015) measured day and night, and in our study 
we instructed the patients not to wear the ActiGraph while sleeping. However, 
this explains a lower average number of counts per minute. Kostrzewa et al. 
(2014) divided his sample into high level PA (HLPA) and low level PA (LLPA). 
Our results were somewhat comparable with the HLPA even if we did not divide 
the sample into high and low exercisers. (Kostrzewa: LLPA: 220,000 
counts/day, HLPA: 400-550,000 counts/day; ANEX: 484,643 – 552,279 
counts/day). Comparing our results with the results of Bratland-Sanda et al. 
(2010b) who divided the sample into excessive exerciser (EE) and non-
excessive exerciser (NEE), our results rather resemble the results of the EE 
(Table 19). There have been more attempts to assess PA in AN than shown in 
Table 19, but the accelerometer devices were older and the outputs were not 
comparable with our results. 
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Table 18: Objectively measured physical activity in anorexia nervosa (2005 to 2016) 
study counts steps MVPA kcal METs 
ANEX Pilot 
study 
- OG: 693 CPM ≈ 484,643 
counts/day 
- IG: 652 CPM ≈ 552,279 
counts/day 
- IG_FU: 670 CPM ≈ 551,632 
counts/day 
- OG : 13.17 
steps/min ≈ 9,210 
steps/day 
- IG: 12.72 steps/min 
≈ 10,807.68 
steps/day 
- IG_FU: 11.77 
steps/min ≈ 9,690.59 
steps/day 
- OG: 8.75% ≈ 61 min/day 
- IG: 7.35% ≈  62 min/day 
- IG_FU: 8.43% ≈ 69 min/day 
- OG:  
262 kcal/day 
- IG:  
249 kcal/day 
- IG_FU:  
303 kcal/day 
- OG: 1.20 METs 
- IG: 1.15 METs 
- IG_FU: 1.20 
METs 
Keyes et al. , 
2015 
 
- Outpatients: 249.73 CPM 
- Inpatients: 223.63 CPM 
 
    
Fernandez-
del-Valle et 
al., 2014 
 
  - Control: 49.62 min/day in MVPA 
- Intervention 44.81 min/day in 
MVPA  
  
Kostrzewa et 
al., 2014 
 
 
- LLPA: ≈ 220,000 counts/day 
- HLPA: ≈ 400-550,000 
counts/day 
    
Hofmann et 
al., 2014 
  
 - Purging AN: 11,011 
steps/day 
- Restricting AN: 9,804 
steps/day  
- Atypical AN: 9,307 
steps/day 
  - Purging AN:  
1.85 METs 
- Restricting AN: 
1.83 METs 
- Atypical AN:  
1.80 METs 
ElGhoch et 
al., 2013 
 
 8563.1 steps/day     
Alberti et al., 
2013 
 
    99.5 min/day in MVPA    
Carrera et 
al., 2012 
 
- Warm group: 230,068 
counts/day 
- Cold group: 347,266 
counts/day 
 
 - warm group: 3.78 % in MVPA 
- cold group: 6.47 % in MVPA 
  
Dellava et al., 
2012 
 
91,762 counts/day 
(weight recovered AN) 
    
Bratland-
Sanda et al., 
2010 
 
- Admission: 
 EE: 844 CPM, NEE: 526 CPM 
- Midway inpatient therapy:  
 EE: 649 CPM, NEE: 550 CPM 
- Discharge:  
 EE: 752 CPM, NEE: 403 CPM 
    
Hechler et 
al., 2008 
 
842 CPM  103 min/day in MVPA   
Birmingham 
et al., 2005 
   251.1 
kcal/day 
 
ANEX: anorexia nervosa and exercise, OG: outpatient group, IG: inpatient group, IG_FU: inpatient group at follow-up, 
AN: anorexia nervosa, PA: physical activity, kcal: kilocalories, MET: Metabolic Equivalent of Task, MVPA: moderate to 
vigorous physical activity, CPM: counts per minute, EE: excessive exerciser, NEE: non-excessive exerciser, HLPA: high 
level physical activity, LLPA: low level physical activity  
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Self-perceived PA assessment has been used much more often than 
accelerometry, and the IPAQ is one of the most often used methods. In the 
review of Loyen et al. (2016) 25 articles measuring physical activity in the 
general population in Europe were included. Sixteen of those studies used the 
IPAQ. The results of the included studies vary significantly. Fourty-five minutes 
per week in moderate to vigorous PA (MVPA) were measured in Malta, while 
960 minutes per week in MVPA have been assessed in the Netherlands (Loyen 
et al., 2016). In the ANEX pilot study the AN patients had a mean of 852 
minutes per week in MVPA in the OG and 155 minutes per week in the IG. So 
the outpatients of the ANEX pilot study reported very high levels of PA 
compared with healthy individuals, while the inpatients reported rather low PA 
levels compared with healthy individuals. The reasons for the large differences 
of self-perceived PA levels between inpatients and outpatients are discussed 
below.   
4.2.2 Comparison of outpatients and inpatients 
4.2.2.1 Objective physical activity  
There were no substantial effects in objectively measured PA between the IG 
and the OG. Taking weak effects into account, the IG had a longer duration of 
PA per day, meaning that the time spent active was higher in the IG than in the 
OG. The reason for this could be the longer wear time of the ActiGraph device 
in the IG. Longer wear time comes about as a result of time spent in bed or 
showering where the participants were instructed not to wear the ActiGraph 
(Trost, McIver, & Pate, 2005) (P.S. Freedson, Melanson, & Sirard, 1998). 
Another reason for a longer wear time of the ActiGraph device could have been 
better compliance (Gummer et al, 2015). Comparing levels of activity, the 
percentage of time in MVPA was slightly lower among the IG. This is confirmed 
when comparing the number of steps per minute, the number of kilocalories per 
day and the counts per minute. Those parameters are not dependent on the 
wear time because their total values have been divided by the wear time before 
the final calculations. The IG was slightly less active than the OG, which 
supports our assumption. To conclude, the accelerometry data showed that the 
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inpatients were active for a longer period of time with less intensity, while the 
outpatients were active for a shorter period of time with higher intensities. This 
effect can be explained by the patients’ setting: Inpatients do not have to go to 
work and they have a lot of time during the day, so they are able to spend more 
time being active. Additionally, inpatients tend to be more compliant because 
they are controlled by the inpatient staff if they wear the ActiGraph. The slightly 
lower intensities of PA in the IG can be explained because inpatients were 
sicker, more underweight and weaker than the outpatients, so their drive to 
exercise could be already satisfied by low PA (LPA) (Keyes et al., 2015). LPA 
includes, for example, walking which was indicated as a frequent activity by the 
participants of this study. The OG had slightly higher mean BMI, shorter 
duration of illness and fewer comorbidities. It can, therefore, be assumed that 
they were stronger than the IG which explains that they tolerated higher levels 
of PA, meaning a higher percentage of time was spent in moderate to vigorous 
PA (MVPA). One previous study also compared the objectively measured PA 
levels of outpatients and inpatients with AN (Keyes et al., 2015). With the help 
of accelerometry assessment they found no differences in accelerometer 
assessed PA, similar to this study. However, there was a tendency toward 
fewer counts per minutes (CPM) in inpatients than in outpatients. CPM were the 
only output of accelerometry documented by Keyes at al. (2015), so it was not 
possible to compare patterns of activity in a more detailed way. This shows that 
outpatients could be more active than inpatients, which is problematic because 
it is not controlled in any way. Additionally, it can be seen that a certain control, 
for example by inpatient staff could help to increase the wear time of the 
accelerometer.  
4.2.2.2 Subjective physical activity  
In contrast to the results of the accelerometer assessed data, the self-perceived 
measurement of PA showed significant differences between inpatients and 
outpatients. A detailed discussion of the reasons for the differences between 
accelerometry measured PA and self-perceived PA can be found below. 
Outpatients reported significantly higher performed vigorous PA (VPA) and 
significantly higher kilocalories spent per day than inpatients. The OG reported 
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to be active twice as long as the IG, meaning the total amount of activity during 
one week. The OG also reported spending three times as much time in 
moderate to vigorous PA (MVPA) than the IG with higher perceived intensities 
of PA in the OG. Moreover, all other parameters of subjectively measured PA 
are higher in the OG. The commitment to exercise has been shown to be 
significantly higher in the OG than in the IG. The OG seemed to estimate their 
activity much higher than the IG, but if objectively measured there is not a big 
difference between the activity levels of the two groups. One reason for this can 
be that the IG underestimated their PA while at the same time the OG 
overestimated their PA. Another reason could be a different sense of what can 
be defined as PA. Walking, for example, does not count as PA for some 
patients with AN. (Bratland-Sanda, Sundgot-Borgen, et al., 2010a). Findings 
like these have also been made by Keyes et al. (2015). They found that the AN 
outpatients reported more MVPA than AN inpatients and healthy controls, even 
though when objectively measured, there was no difference in PA. Alberti et al. 
measured subjective PA by using the IPAQ, and they found much higher values 
for MVPA compared to this study. Their sample consisted only of inpatients. 
Keyes et al. (2015) explains the overestimation of PA by AN patients in general 
by the fact that they are “physically compromised” (Keyes et al., 2015). But this 
does not explain why outpatients reported more PA than inpatients, because it 
can be assumed that the inpatients with AN were even more physically 
compromised than the outpatients with AN. Another assumption why the OG 
showed higher subjective PA than the IG can be the feeling of guilt when 
omitting an activity, which correlates with the amount of PA in both the IG and 
OG. The feeling of guilt is represented in the seventh item of the CES. The OG 
had higher scores in CES_07 than the IG. Mond et al. (Mond, Hay, Rodgers, & 
Owen, 2006) stated that the feeling of guilt when leaving out an activity is 
essential in the detection of eating disorders. The commitment to exercise has 
also been assessed by Keyes et al. (2015) and Bratland-Sanda, Sundgot-
Borgen et al. (2010b). They both found high scores in the CES in patients with 
AN in general and significant correlations between high levels of measured PA 
and high scores in the CES. However, they did not separately evaluate the 
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CES_07 score. Keyes et al. (2015) did not find any differences between 
outpatients and inpatients in the CES. 
Reasons for exercise were very similar among the OG and IG. In both groups 
weight control and fitness were most important, followed by mood and tone. The 
least important reason for exercise in both groups was physical attractiveness 
and enjoyment. However, there were big differences in the correlation of 
reasons for exercise with PA parameters between inpatients and outpatients. 
Weight control as a reason for PA correlated significantly positive with PA in the 
OG, while it was significantly negative in the IG. This shows that the cognitive 
impulsion behind being active is different between groups. This becomes 
confirmed when viewing health as a reason for exercise, which also had an 
opposite correlation in the IG and OG. Health correlated significantly negative 
with PA parameters in the OG and significantly positive in the IG. Being 
healthier motivated the IG to be more active. For the OG being healthy was 
rather connected with less PA. In the OG there was also a negative correlation 
between enjoyment and time spent in LPA. Activities in LPA include slow 
walking, slow cycling, or yoga, which are not the most fun sports activities, 
which makes it understandable that the OG did not perform LPA for enjoyment. 
In conclusion it can be said that the OG had higher levels of PA when they 
wanted to control their weight, while the IG had higher levels of PA when they 
exercised for health purposes. The version of the OG, being active to control 
weight, is often assumed to be the reason for exercise among AN patients, 
meaning they perform PA with the aim of losing weight (Thome & Espelage, 
2007). Bratland-Sanda, Sundgot-Borgen et al. (2010b) showed that weight 
control was the most important reason for exercise in their samples. However, 
comparing excessive and non-excessive exercisers, they also demonstrated 
that negative affect regulation as a reason for exercise is more important for 
excessive exercisers. So excessive PA can be seen as an affect regulation 
strategy.  
Keyes et al. (2015) found that improving tone was very important for AN 
patients as a reason for exercising while health and enjoyment were less 
important. Especially among outpatients, exercising for the reason of health was 
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not important (Keyes et al., 2015). Dellava et al. (2012) found that health was 
the most important reason for patients with AN to be active, followed by fitness 
and mood. All this showed that in AN the motivation for exercise is contradictive 
and cannot be reduced to the “cognitive desire to lose weight” (Keyes et al., 
2015).   
4.2.2.3 General and eating disorder psychopathology 
There were no differences between the IG and OG in the results of any 
psychometric questionnaire beside social insecurity as an item of the EDI, 
which was shown to be higher among inpatients. This is consistent with the data 
of Keyes et al. (2015) who also did not find any differences in psychopathology 
between their inpatient and their outpatient group. However, there were some 
small and medium effects between the OG and IG. Perceived stress, 
depression, and eating disorder pathology were slightly higher in the IG. The 
correlations of psychometric data with objectively measured PA were also 
similar in IG and OG and show that high levels of PA went along with low 
depression, low stress, low worries, low shape and weight concerns, and a 
good body image. These results remain in contrast to previous findings. 
According to Meyer et al. (2011) eating disorder pathology and affect regulation 
belong to the main correlates of high physical activity. Also Bratland-Sanda et 
al. (2010a) stated that PA is a method for coping with negative affect. Similar 
results were found by Keyes et al. who identified the global EDE score as a 
predictor for the drive to exercise in patients with AN. They also found a positive 
correlation between EDE questionnaires and peak activity measured by 
accelerometry. These findings are contradictory, because Carrera et al. (2012) 
did not identify anxiety or depression as a relevant predictor for high PA levels 
in AN patients. Additionally, they did not find any correlations between eating 
disorder pathology and accelerometry assessed PA data. A negative correlation 
of psychopathology with PA as found in the results of this study showed that 
very active patients with AN had a better psychological constitution than 
patients with lower levels of PA. This is consistent with investigations made by 
Strohle et al. (2009), who found that depressive symptoms could be reduced in 
healthy people through regular PA. The significant and positive correlation 
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between the body image questionnaire concurred that good feelings of one’s 
own body lead toward more PA in AN. All this showed that physical activity can 
be good for patients with AN. Kostrzewa et al. (2014) confirmed that high levels 
of PA do not necessarily result in poorer treatment outcomes. They further 
stated that high levels of PA could have a positive effect on the psychological 
status of patients with AN. The positive effects of PA should be fully utilized in 
the treatment of PA. Of course this should not exceed an intensity of PA that 
harms underweight patients. The type of activity has to be carefully chosen 
(Schlegel, Hartmann, Fuchs, & Zeeck, 2015). Muscle strengthening, for 
example, can be assumed to be better for patients with AN than fat-burning 
activities (Fernandez-del Valle et al, 2014). Schlegel, Hartmann, Fuchs and 
Zeeck (2015) developed a sports program for patients with AN that has the aim 
to “reduce unhealthy exercising.” Fernandez-del-Valle et al. (2014) found that 
eight weeks of high-intensity resistance training increased strength and agility in 
patients with AN without weight loss. Additionally, current evidence of exercise 
intervention in AN is still weak (Zunker et al., 2011), especially in combination 
with the effects of exercise intervention on general psychopathology and on 
eating disorder psychopathology.  
Interestingly there was a connection between social insecurity and physical 
activity, showing that participants with high scores in social insecurity tended to 
be less active, especially in the OG, but also in the IG. Kostrzewa et al. (2014) 
found that weight recovered patients had significantly lower scores in social 
insecurity than patients who were not weight recovered. This confirms again 
that there could be a connection between psychological well-being, specifically 
social interaction, and physical activity.  
4.2.3 Changes of physical activity behavior after treatment 
There is a distinct tendency that the overall activity and the intensity of PA 
increased slightly after hospitalization: the IG_FU had more counts per minute 
(CPM) and more kilocalories per day and they spent more percent of time in 
MVPA. This slight increase of activity after inpatient treatment can be explained 
variously: Patients were healthier after treatment, some of them were even 
weight recovered, so they had greater capacity for activity. They also had an 
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improved psychological condition, which was shown by better results in their 
eating disorder and general psychometric questionnaires. Additionally, the 
IG_FU were not controlled any longer by inpatient staff. Being out of the 
hospital offered more possibilities for being active, wherever and whenever the 
patients liked. Although the PA levels of both inpatients and inpatients at follow-
up were evaluated as rather elevated compared with healthy individuals, it is 
important to supervise AN patients after treatment (K. Giel et al., 2013). In 
follow-up examinations PA should be mandatory issue to discuss with the 
patients.  
Kostrezwa et al. (2014) who measured PA one year after treatment did not find 
a significant increase after treatment. They especially stated that high levels of 
PA did not have a negative effect on recovery rate. They even suggested that 
patients with high PA levels can achieve a better treatment outcome when their 
PA level is partly diminished and remains lower. The reason for this is that they 
found that high levels of PA lead to a higher percent of body fat after recovery, 
which leads to higher levels of leptin. Leptin has been shown to reduce stress 
(Malendowicz, Rucinski, Belloni, Ziolkowska, & Nussdorfer, 2007). Dellava et al. 
(2012) measured PA in recovered PA patients three years after weight 
restoration. They found that AN patients had only slightly higher PA levels than 
healthy controls. Even if those differences are very small, the authors point out 
that “very small differences in energy balance can result in drastic differences in 
BMI over time” (Dellava et al., 2012). Kaye et al. (1986) found that recent weight 
recovered AN patients who were assessed two to four weeks after recovery 
showed higher PA levels than long-term weight recovered AN patients, who 
were measured six month after recovery. This represents a normalization of 
elevated PA levels over time. All this shows that more evidence of the long-term 
development of PA in AN after inpatient treatment is needed.  
However, in the results of this study correlations between the PA level at follow-
up and the psychopathology showed very similar tendencies in the IG. Low 
depression, low stress and low ED pathology were connected with high PA 
levels after treatment and high scores in general and ED psychopathology were 
connected with low PA levels. This poses the question as to whether general 
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and eating disorder psychopathology would improve if PA levels were artificially 
raised in AN patients during treatment, for example with exercise interventions.   
4.3 Feasibility  
The question of whether accelerometry is a useful method to measure PA in AN 
can be answered when we try to understand the patients who do not want to 
participate in an accelerometry measurement. With this understanding the 
usage of accelerometry can be improved. Additionally, advantages and 
disadvantages of objective PA measurement, self-perceived PA, and the 
combination of both should be understood to make the correct decision when 
choosing the method of PA assessment in AN.  
4.3.1 Study participation  
Almost 50% of all AN patients who were asked to take part in the ANEX study 
refused to participate. Thus, the question what distinguishes those who refused 
participation in comparison to the participants is significant. We compared the 
age, the BMI, the duration of illness, the clinical basis documentation, the PSQ 
and the PHQ. Some moderate effects were seen. Perceived stress was higher 
among those who refused; perfectionism was higher in participants and maturity 
fears were lower in participants. Additionally, study participants achieved higher 
education levels than those who refused to participate.  
When asked why they had declined to take part in the ANEX study, stress was 
the most frequently mentioned reason. Higher perceived stress as a result of 
psychometric data underlined that statement. The accelerometry assessment 
simply consisted out of wearing a belt around the body, which worked on its 
own and did not require additional operation by the study participant. The 
ActiGraph exclusively measured acceleration of the body. There was no 
integrated GPS that could track the patient’s location. Literature indicates that 
dropouts and refusals are a problem in AN (Gummer et al., 2015). Given this 
circumstance, several methods to improve compliance and participation were 
performed in this pilot study: 
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- The study instructor had a lengthy individual conversation with each potential 
participant, precisely explaining the study and the device.  
- The participant was able to think about her decision and was contacted again 
after a few days. 
- When a patient decided to participate, email or phone contacts were 
exchanged so that she could contact the instructor with questions or 
problems. 
- The instructor contacted the participant once during the accelerometry 
assessment to determine if everything was going well. 
 
The fact that perfectionism was higher among study participants than refusals 
could be the manifestation of perfectionism itself. If a person strives for 
perfection, it is more difficult to refuse participation, especially if it is shown that 
there is a large interest in the department that AN patients participate in the 
study. However, this does not explain why accelerometry assessment is a 
problem for patients with AN. To the contrary, it could be that some participants 
were uncomfortable with participation, but they took part in the study because of 
their perfectionism, meaning that for them it was very hard to say “no.” 
Those who agreed to participate had a more advanced educational level than 
their counterparts. It can be assumed that there was a higher understanding of 
the study and the accelerometry measurement among the participants. A clear 
understanding of the study information avoids misunderstandings, resulting in 
fewer doubts about control, observation, or side effects of wearing the 
accelerometer device. Another reason for increased participation among 
patients with higher education could be compassion with the study instructor, 
because they remembered a similar situation in which they too had to find study 
participants.  
Taking all this this into consideration, there must have been a reason for AN 
patients that caused them to reject wearing the devices even though it was 
seen objectively as not stressful. One possible idea as to why accelerometry 
assessment was seen as stressful for AN patients could be the fact that they 
have a very high need for autonomy, which is restricted by inpatient treatment. 
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This has been previously discussed by Gummer et al. (2015). Inpatient therapy 
controls the eating behavior in a very extreme way, so that it seems far too 
much outside control for a patient with AN when the daily activity is also 
observed closely. El Ghoch et al. (2013) found differences between dropouts 
and completers in their study. They measured that the dropouts had higher 
(almost double) MVPA than completers at the onset of treatment (El Ghoch et 
al., 2013). This shows an interaction between the amount of PA and participant 
compliance. Ultimately, those patients with high levels of PA also had feelings 
of shame regarding this and simply did not want to divulge this in a study. To 
reduce stress and shame and to improve the compliance in further PA 
measurements in AN, an effective concept has to be developed for PA 
assessment in AN (a proposal for a concept can be found further below in this 
thesis). Moreover, PA assessment in AN has to be led by staff who are well 
informed of the doubts that AN participants have with accelerometry. This 
means that awareness that PA assessment is stressful for patients with AN is 
very important for further investigations.  
4.3.2 Discussion of methods: ActiGraph and IPAQ  
The results of the ANEX pilot study showed significant differences between 
objective PA assessment with the ActiGraph and subjective evaluation of PA 
with the International Physical Activity Questionnaire (IPAQ). At first sight those 
two very different methods appear advantageous to compare, because of the 
similar differentiation into hours in vigorous PA, moderate PA, and low or 
walking PA. Moreover, both results can be transformed into kilocalories per day, 
which is another useful parameter to analyze and compare activity. However, in 
our study AN patients underestimated the overall time of activity in the IPAQ 
compared to the ActiGraph: 16 hours of activity on an average was documented 
in the IPAQ compared to around 84 hours of activity per week measured by the 
ActiGraph. The walking hours reported in the IPAQ are especially lower than 
the LPA hours measured by the ActiGraph. This could be the case because the 
IPAQ specifies walking hours. Therefore, patients would try to recall the hours 
in the week where they went for a walk, but would neglect the walks to the toilet 
or to the meal rooms or general daily walking. Of course, those low level 
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activities were documented very exactly by the accelerometer. The 
accelerometer assesses every kind of activity, regardless of how low, which is 
very important in AN because low level activity, for example, fidgeting has been 
shown to contribute a lot of energy expenditure (Levine, Schleusner, & Jensen, 
2000). Fidgeting has been observed quite often in patients with AN (Hebebrand 
et al., 2003). So the IPAQ might be a simple method for achieving an overview 
of self-perceived activity, but it does not give an exact image of activity levels. 
Alberti et al. (2013) and Bratland-Sanda et al. (2010a) also found that AN 
patients under-reported PA in comparison to accelerometry assessment. The 
title of the study of Bratland-Sanda et al. (2010a) concludes this very well: “I’m 
not physically active, I only go for walks.” Another simple limitation of subjective 
PA measurement is the dependence on the recall ability of the patients.  
Not only the IPAQ questionnaire but also the accelerometer can contribute to 
contradictory findings. Accelerometry assessment has been validated and it has 
been shown that it measures PA adequately (Westerterp & Bouten, 1997). It is 
not certain if some types of activity, for example, cycling or walking with heavy 
bags or walking stairs, can be recorded accurately by the accelerometer (Keyes 
et al., 2015). This can be demonstrated with one example of our results: 
accelerometer assessed PA increased in all different dimensions after 
treatment, comparing IG and IG_FU. Kilocalories, CPM, MET rates and percent 
of time in MVPA increased after treatment. The only parameter that did not 
increase, but rather decreased after treatment were steps per minute. However, 
in retrospect it is not possible to determine why this is the case. We can assume 
that patients were more active in other activities, such as climbing, muscle 
strengthening, cycling or volleyball, which lead to higher waste of kilocalories or 
higher CPM, but do not require a lot of steps.  
Another problem with the accelerometers is compliance. As previously 
discussed, wearing an accelerometer is a very stressful task for patients with 
AN and it is difficult to control that fact that the accelerometer is worn 
throughout the whole assessment period (Bratland-Sanda, Sundgot-Borgen, et 
al., 2010b) (Gummer et al., 2015). In the case of missing data, it is not possible 
to determine if this is due to technological issues or due to a lack of compliance 
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(El Ghoch et al., 2013). A very simple reason for this, besides the psychological 
aspects, could be vanity. The ActiGraph is a red plastic cube, which is not very 
attractive. To improve compliance, perhaps a more attractive design would 
encourage young females to wear the device. It might also be easier to get AN 
patients to wear an accelerometry bracelet rather than a belt around the waist. 
However, the limitation in both objective and subjective PA assessment in 
patients with AN confirms that best practice for the quantification of PA in AN is 
the combination of both (Gummer et al., 2015). IPAQ questionnaires for the 
rough evaluation of PA and for alignment with the literature and accelerometer 
assessment for more detailed PA patterns could be controlled by the 
information of the questionnaires or by using an activity diary. Therefore, even if 
the comparison of the results of the two methods is difficult, a combination of 
both methods in future research is inevitable. However, results must be 
evaluated separately.  
4.4 Strengths and limitations 
This is the first study that concludes all literature about objective PA 
assessment in AN in which accelerometry as a method to measure PA in AN 
has been established. Also, it is the first study that attempts to relate the results 
to previous data and data of the general population so that the extent of 
hyperactivity can be ranked. Additionally, it is the first critical discussion of 
different methods to assess PA in AN. 
The OG consisted of 13 participants and the IG consisted of 12 participants. 
These are very small sample sizes, even if ANEX was planned to be an 
explorative study. Higher sample sizes would increase the validity of the results.  
4.5 Conclusion  
The summary of previous studies in a systematic review of the literature 
showed that accelerometry seems to be a valid method to measure PA in AN. 
This justifies the establishment of accelerometry as a PA assessment method in 
AN. Many different kinds of measurements, devices, and samples have been 
previously used, which resulted in a variety of different outcomes. However, this 
represents the complexity of PA assessment in AN. A combination of 
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accelerometry with an activity diary, a nurse evaluation, standardized 
questionnaires, and interviews are important. Moreover, weak study 
participation and problems with dropouts occurred frequently and showed that 
PA is more relevant for patients with AN than evidence suggests.  
The results of the ANEX pilot study showed that both outpatients and inpatients 
performed very high levels of PA. This has to be taken seriously because the 
balance of caloric consumptions shifts toward weight reduction over time even if 
the imbalance is only very small. This is especially important to know about 
outpatients where PA behavior cannot be controlled in any way. Inpatients 
demonstrated a tendency to be active at a low level, but for long periods of 
time. Low level activity can be unrecognized from the outside so that there is a 
danger of underestimation of the loss of calories through light PA (LPA) over 
time. There was no remarkable difference in objectively measured PA levels of 
outpatients and inpatients, but there is a difference between outpatients and 
inpatients regarding the reason for exercise. Outpatients exercised for weight 
control, while inpatients exercised to improve their health. Additionally, 
outpatients rated their PA to be much higher than the inpatients. This shows 
that inpatient treatment, even if it did not have an effect on the PA level itself, 
changed the attitudes and the understanding of PA. It also shows that PA is 
much more than a method to control weight for patients with AN. The fact that 
reasons for exercise can be very controversial and individual in patients is 
important to know for AN treatment. In inpatients and outpatients high levels of 
PA went along with low depression, low shape concerns, low weight concerns, 
a good body image, low worries, and low stress. High PA levels not only take 
the risk of losing weight but also indicate the subjective well-being of AN 
patients. Inpatient treatment should utilize healthy exercise as a supervised 
intervention so that positive effects of PA can be utilized and negative effects 
can be avoided. 
Following treatment, the PA levels slightly increased. This has to be taken 
seriously, too, because even a small loss of calories through exercise and the 
new situation of food intake no longer being controlled can put the weight 
balance out of control.  
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The results of the review and the pilot study showed that accelerometry is an 
adequate method to assess PA in AN when it is combined with self-perceived or 
otherwise subjective PA assessment. Accelerometry itself is expedient in AN, 
because it perceives very small amounts of activity. However, the usage of 
accelerometry in AN is not trivial, and should be planned carefully as described 
below. Accelerometer assessment is a stress factor for patients with AN 
explaining the high rates of study refusals. Patients with AN are controlled in 
their all-day life, especially in their food intake and during inpatient treatment. 
PA is a means of maintaining autonomy and control, which is extremely 
important for patients with AN.  
All this underlines the high psychological importance and the high complexity of 
PA in patients, which should be the topic for future investigations. 
4.6 Implications for further investigations and treatment 
To understand the importance and the complexity of PA for patients with AN, it 
is necessary to confirm and control the findings of this pilot study with larger 
samples of patients with PA and with a healthy control group. The studies 
should be designed as long-term measurements to assess the development of 
PA not only one month but also years after inpatient treatment. The assessment 
of psychological well-being, eating disorder pathology, social interaction, 
commitment to exercise, and the reasons for exercise is necessary and should 
be mandatory going hand-in-hand with the objective PA measurement. The 
combination of accelerometry and the IPAQ questionnaire as a subjective PA 
assessment method is important. In an inpatient setting the observation of 
nurses can be used to get an additional objective rating of PA (van Elburg et al., 
2007) (Gummer et al, 2015).  
PA assessment in AN is complex. It should always be planned very carefully 
with the knowledge that PA assessment represents a stressful situation for 
patients with AN. Recommendations for future studies assessing physical 
activity in anorexia nervosa to reduce stress in AN patients and improve study 
participation are subsequently listed: 
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- Study staff has to be aware of the doubts that AN patients have with PA 
assessment, especially with accelerometry. 
- The functionality of accelerometry has to be explained carefully to the 
patients to avoid doubts of GPS tracking or control. 
- Anonymity must be ensured. 
- Effective time management is required to make use of as little time as 
possible. 
- The study should not be made by the same department that makes the 
treatment to reduce the patients’ doubts of control. 
- A small financial compensation can serve as motivation. 
 
There should be broader research about exercise interventions during 
treatment to determine if PA can improve mood and eating disorder pathology 
or even weight. In this context it is also important to establish exactly which 
types, frequencies, and levels of exercise or sports are helpful in patients with 
AN (Zunker et al., 2011) both from a short- and long-term point of view.  
As PA seems to be a core factor of illness origin, duration, development, and 
outcome, PA assessment should become a standard measurement in AN 
treatment. PA levels should be tracked throughout the treatment process. 
Finally, broad data about PA levels in the healthy population is needed to be 
able to align pathological PA levels of unhealthy individuals, such as patients 
with AN. 
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5 Abstract  
Anorexia nervosa (AN) is the mental illness with the highest standardized 
mortality rates. Not only restrictive eating behavior, low body weight, and fear of 
weight gain, but also early onset and chronic somatic and mental complications 
make it a very dangerous disease that has not yet been fully understood. Up to 
80% of AN patients engage in high levels of physical activity (PA), which leads 
to an even larger imbalance of body weight.  
PA in AN is complex and cannot be reduced to a conscious action with the aim 
of losing weight. There are several forms of manifestations, multiple definitions, 
and various explanations of the origin. Additionally, there are many severe 
complications as consequences of PA in AN. These complications include, for 
example, longer duration of the illness, longer treatment durations, higher 
relapse rates, and more psychiatric comorbidities. Thus, the quantification of PA 
in AN is important. In literature PA in AN is most often carried out through 
subjective methods such as questionnaires, self-ratings, or interviews. 
Unfortunately, the precision of these methods is not very high. However, 
accelerometry is an objective method, which measures PA exactly through the 
assessment of triaxial acceleration of the body. 
 
The aim of this study was to establish accelerometry as a method of PA 
assessment in AN and to evaluate its feasibility in a pilot study. Therefore, the 
focus of this thesis lies on the methodology. To establish accelerometry in AN 
we concluded all literature that measured PA in AN with accelerometry in a 
systematic review. Subsequently, in the ANEX pilot study we measured PA in 
AN with the ActiGraph in 13 outpatients and 12 inpatients. The inpatients have 
been followed-up one month after treatment. Moreover, we assessed self-
perceived PA with questionnaires as well as eating disorder pathology, stress, 
and depression. Many AN patients refused to participate, and in the ANEX pilot 
study we tried to determine the reasons for this.  
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Both AN outpatients and inpatients in our study had high levels of PA compared 
with standard activity levels of the general healthy population. Comparing 
outpatients and inpatients, there were no differences in objectively measured 
PA. However, the self-perceived PA and the commitment to exercise were 
significantly higher among outpatients. At follow-up, the objectively measured 
PA increased slightly. All in all, there was a positive correlation between 
psychological well-being and high levels of PA in all groups. Comparing study 
refusals and study participants, we found that those who refused perceived 
greater stress than those who participated.  
 
Accelerometry seems to be a feasible method for measuring PA in AN 
especially because of its ability to measure activity patterns in time, activity 
levels and even tiny movements that are not self-perceived as activity but 
contribute to energy expenditure. 
However, accelerometry can be a stressful task for patients with AN. Study staff 
should be aware of the high need for autonomy and self-control in AN. The 
ANEX pilot study was projected to be a pre-study for a larger ANEX study with 
much larger samples and more long-term results. Additionally, improved 
standard data about PA in healthy individuals is needed to compare results and 
to classify dangerous or pathological PA levels in AN. It is important to control 
PA levels after inpatient treatment in follow-up assessments. For outpatient 
therapy it is important to know that high levels of PA often play a significant role 
in the maintenance of the illness. In addition, it would be interesting to 
determine more about exercise interventions, its usability in AN treatment and 
its interaction with psychological well-being.  
All this should contribute to a better understanding of PA in AN which again 
should be applied in further investigations and treatment to improve the 
prognosis in AN. 
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Abstract in German 
Über alle psychischen Erkrankungen hinweg hat Anorexia nervosa (AN) die 
höchste standardisierte Mortalitätsrate. Ausschlaggebend dafür sind nicht nur 
das niedrige Gewicht, das restriktive Essverhalten und die massive Angst vor 
dem Zunehmen: Das niedrige Erkrankungsalter und chronische Verläufe mit 
sowohl somatischen als auch psychischen Komplikationen machen es zu einer 
gefährlichen Erkrankung, die bis heute nicht im Detail verstanden ist. Dazu 
kommt, dass bis zu 80% der AN Patientinnen sich überdurchschnittlich viel 
bewegen, was das Körpergewicht noch mehr aus dem Gleichgewicht bringt.  
Körperliche Aktivität bei AN ist ein komplexes Thema und sollte nicht nur als 
eine Methode zur Gewichtsreduktion betrachtet werden: Aufgrund von 
unterschiedlichsten Manifestationen gibt es auch zahlreiche Definitionen und 
Versuche die Ursache der Hyperaktivität bei AN zu erklären. Außerdem gibt es 
ernstzunehmende Komplikationen als Konsequenz. Die Quantifizierung von 
Bewegung bei AN spielt deshalb eine immer größere Rolle in der Forschung 
und auch im klinischen Alltag. In bestehender Literatur wurde Bewegung 
meistens mit subjektiven Methoden wie z.B. Fragebögen oder Interviews 
gemessen. Diese spiegeln die körperliche Aktivität jedoch nicht sehr exakt 
wieder. Akzelerometrie hingegen ist ein ein objektives Verfahren, welches 
Bewegungen des Körpers durch triaxiale Beschleunigungsmessung sehr genau 
erfasst.  
Das Ziel dieser Studie war die Etablierung von Akzelerometrie als objektive 
Messmethode für Bewegung in AN und die Prüfung ihrer Machbarkeit. Der 
Fokus dieser Arbeit lag also auf der Untersuchung der Methode. Zunächst 
wurde die bereits bestehende Literatur zur objektiven Bewegungsanalyse bei 
AN in einem systematischen Review zusammengefasst. Daraufhin wurden in 
der ANEX Pilot Studie bei 13 ambulanten und zwölf stationären Probandinnen 
objektiv die Aktivität gemessen. Die zwölf stationären Patientinnen hatten eine 
weitere Messung einen Monat nach Entlassung von Station. Außerdem wurden 
Fragebögen zur subjektiven Erfassung der Aktivität ausgefüllt, sowie 
psychometrische Fragebögen und Essstörungs-Fragebögen. Fast 50% der AN 
Patientinnen lehnten die Teilnahme an der Studie ab.  
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Sowohl die stationären als auch die ambulanten AN Patientinnen waren 
überdurchschnittlich aktiv. Beim Vergleich von den stationären und den 
ambulanten Patientinnen fiel auf, dass es kaum Unterschiede in der objektiv 
gemessenen Bewegung gab. Allerdings gab es große Unterschiede in der 
subjektiv gemessenen Bewegung durch Fragebögen, sowie in der Bewertung 
der körperlichen Aktivität. Einen Monat nach stationärer Therapie stieg die 
körperliche Aktivität leicht an. Insgesamt gab es eine positive Korrelation 
zwischen viel Bewegung und psychologischem Wohlbefinden in allen Gruppen. 
Studienverweigerer waren jedoch gestresster als die Teilnehmer. 
Akzelerometrie scheint eine sinnvolle und valide Methode zur 
Aktivitätsmessung bei AN zu sein, vor allem durch die Fähigkeit auch 
Aktivitätslevel sowie Aktivitätsmuster bezogen auf die Zeit und kleinste 
Bewegungen zu erfassen, die subjektiv nicht wahrgenommen werden, aber 
dennoch zur Energiebilanz beitragen und bei AN relevant sind. Trotzdem sollte 
Akzelerometrie in AN immer vorausschauend und bedacht geplant werden, weil 
Bewegungsmessung für AN Patienten subjektiv belastend sein kann. Das 
große Bedürfnis von AN Patientinnen für Autonomie und Selbstkontrolle muss 
berücksichtigt werden.  
Die ANEX Pilot Studie sollte in größerem Ausmaß wiederholt werden mit 
größeren Stichproben und einer längeren Erhebungsspanne. Außerdem sind 
standardisierte Aktivitätslevel der Normalbevölkerung notwendig, um die 
Ergebnisse als pathologisch einordnen zu können. Es ist wichtig, die 
körperliche Aktivität auch nach stationärer Therapie in Folgeuntersuchungen zu 
beobachten. Das gleiche gilt für die ambulante Therapie: Hier ist das 
Bewusstsein der Therapeuten ausschlaggebend, dass körperliche Aktivität eine 
große Rolle in der Aufrechterhaltung der Erkrankung spielt. Es wäre zudem 
interessant mehr über die Wirkung von Sport- oder Bewegungstherapie bei AN 
herauszufinden, insbesondere im Zusammenhang mit psychologischem 
Wohlbefinden. 
All das sollte zu einem besseren Verständnis der AN beitragen, welches in 
weiteren Studien und in der Therapie angewandt werden kann, um dauerhaft 
die Prognose der AN zu verbessern.  
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Correlation of Commitment to Exercise Scale (CES) and CES_07 (seventh item) with objectively 
measured physical activity parameters 
correlation 
 
all OG IG IG_FU 
CES with LPA  r -0,291 -0,212 0,143 -0,690 
 
p 0,258 0,556 0,760 0,058 
CES_07 with LPA r -0,319 -0,370 -0,134 -0,848** 
 
p 0,212 0,293 0,730 0,002 
CES with MPA r 0,261 0,345 0,071 0,310 
 
p 0,311 0,328 0,879 0,456 
CES_07 with MPA r 0,263 0,721* 0,227 0,049 
 
p 0,309 0,019 0,557 0,894 
CES with VPA r 0,392 0,299 0,523 0,714* 
 
p 0,108 0,402 0,229 0,047 
CES_07 with VPA r 0,285 -0,122 0,691* 0,791** 
 
p 0,252 0,737 0,039 0,006 
CES with MVPA % r 0,223 0,103 0,323 0,476 
 
p 0,373 0,777 0,435 0,233 
CES_07 with MVPA % r 0,333 0,636* 0,391 0,494 
 
p 0,177 0,048 0,263 0,147 
 
OG: outpatient group, IG: inpatient group, IG_FU: Inpatient group at follow-up, CES: Commitment to Exercise 
Scale, CES_07: seventh item of the CES, LPA: light physical activity, MPA: moderate physical activity, VPA: 
vigorous physical activity, MVPA%: percent of time spent in moderate to vigorous physical activity, r: correlation 
coefficent 
* = significance <0,05, ** = significance<0,05 
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Correlation of reasons for exercise (weight control and health) with objectively measured physical 
activity parameters 
correlation 
 
all OG IG IG_FU 
REI (weight control) with steps/min r -0,032 0,662* -0,775* -0,018 
 
p 0,901 0,026 0,041 0,969 
REI (weight control) with CPM  r -0,052 0,385 -0,786* -0,523 
 
p 0,807 0,242 0,043 0,229 
REI (weight control) with MVPA % r -0,108 0,681* -0,818* -0,342 
  p 0,669 0,021 0,024 0,452 
REI (health) with steps/min r 0,273 -0,516 0,821* 0,107 
 
p 0,274 0,104 0,023 0,819 
REI (health) with CPM r 0,250 -0,581 0,815* 0,643 
 
p 0,318 0,061 0,021 0,119 
REI (health) with MVPA % r 0,378 -0,465 0,883** 0,571 
  p 0,121 0,149 0,008 0,18 
 
*= significance p<0,05 
**= significance p<0,01 
OG: outpatient group, IG: inpatient group, IG_FU: inpatient group at follow-up, REI: Reasons for Exercise Inventory, 
CPM: counts per minute, MVPA%: percent of time spent in moderate to vigorous physical activity, r: correlation 
coefficient 
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Correlation of Body Image Questionnaire (BIQ) and objectively measured physical activity 
parameters 
correlation   all OG IG IG_FU 
BIQ-20 (NEB) with CPM r -0,169 -0,269 -0,407 -0,323 
 
p 0,49 0,424 0,317 0,453 
BIQ-20 (NEB) with VPA in h/week r -0,216 -0,252 -0,414 -0,347 
 
p 0,375 0,455 0,355 0,399 
BIQ-20 (NEB) with MVPA % r -0,062 -0,314 -0,506 -0,371 
  p 0,801 0,346 0,201 0,365 
BIQ-20 (PBD) with CPM r 0,584** 0,647* 0,551 0,335 
 
p 0,009 0,031 0,157 0,417 
BIQ-20 (PBD) with VPA in h/week r 0,645 0,689* 0,709 0,443 
 
p 0,003 0,019 0,074 0,272 
BIQ-20 (PBD) with MVPA % r 0,506* 0,287 0,753* 0,551 
 
0,027 0,392 0,031 0,157 
 
OG: outpatient group, IG: inpatient group, IG_FU: Inpatient group at follow-up, BIQ: Body Image Questionnaire, 
NEB: negative evaluation of the body, PBD: perception of body dynamics, CPM: counts per minute, VPA: vigorous 
physical activity, MVPA%: percent of time spent in moderate to vigorous physical activity, r: correlation coefficient  
* = significance <0,05, ** = significance<0,05 
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Correlation of worries, joy and Perceived Stress Questionnaire (PSQ) mean count with objectively 
measured physical activity parameters 
correlation 
 
all OG IG IG_FU 
worries with steps/minute r -0,451* -0,635* -0,391 -0,447 
 
p 0,040 0,049 0,299 0,227 
worries with MPA (h/week) r -0,178 -0,347 -0,209 -0,344 
 
p 0,441 0,326 0,620 0,365 
worries with VPA (h/week) r -0,606** -0,788** -0,739* -0,622 
 
p 0,004 0,007 0,036 0,074 
worries with MVPA % r -0,527* -0,702* -0,547 -0,506 
 
p 0,014 0,024 0,128 0,165 
joy with steps/minute r 0,437* 0,090 0,852** 0,813** 
 
p 0,048 0,804 0,004 0,008 
joy with MPA (h/week) r 0,434* -0,041 0,787* 0,815** 
 
p 0,050 0,910 0,020 0,007 
joy with VPA (h/week) r 0,338 0,360 0,817* 0,786* 
 
p 0,134 0,307 0,013 0,012 
joy with MVPA % r 0,456* 0,142 0,865** 0,790* 
 
p 0,038 0,696 0,003 0,011 
PSQ mean with steps/minute r -0,493* -0,242 -0,613 -0,461 
 
p 0,023 0,501 0,079 0,212 
PSQ mean with MPA (h/week) r -0,332 -0,040 -0,502 -0,370 
 
p 0,154 0,912 0,205 0,327 
PSQ mean with VPA (h/week) r -0,509* -0,551 -0,845** -0,658 
 
p 0,018 0,099 0,008 0,054 
PSQ mean with MVPA % r -0,568** -0,364 -0,734* -0,573 
 
p 0,007 0,302 0,024 0,106 
OG: outpatient group, IG: inpatient group, IG_FU: Inpatient group at follow-up, PSQ: Perceived Stress Questionnaire, 
MPA: moderate physical activity, VPA: vigorous physical activity, MVPA%: percent of time spent in moderate to 
vigorous physical activity, r: correlation coefficient 
* = significance <0,05, ** = significance<0,05 
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Correlation of social insecurity and ineffectiveness (EDI) with objectively measured physical 
activity parameters 
correlation 
 
all OG IG IG_FU 
social insecurity with CPM r -0,410 -0,769* -0,154 -0,156 
 
p 0,104 0,015 0,693 0,689 
social insecurity with VPA (h/week) r -0,104 -0,702* -0,593 -0,386 
 
p 0,664 0,035 0,121 0,305 
ineffectiveness with CPM r -0,486* -0,687* -0,398 -0,453 
 
p 0,030 0,041 0,289 0,221 
ineffectiveness with VPA (h/week) r -0,270 -0,680* -0,671 -0,442 
 
p 0,250 0,044 0,069 0,258 
EDI: Eating Disorder Inventory, OG: outpatient group, IG: inpatient group, IG_FU: Inpatient group at follow-up, CPM: 
counts per minute, VPA: vigorous physical activity, r: correlation coefficient 
* = significance <0,05, ** = significance<0,05 
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